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Abstract
Sporadic breast cancers are mainly attributable to long-term exposure to environmental
factors, via a multi-year, multi-step, and multi-path process of tumorigenesis involving
cumulative genetic and epigenetic alterations in the chronic carcinogenesis of breast cells from a
non-cancerous stage to precancerous and cancerous stages. Epidemiologic and experimental
studies have suggested that various dietary compounds like green tea and grape seed may be
used as preventive agents for breast cancer control. In this research, I have developed a cellular
model that mimics breast cell carcinogenesis chronically induced by cumulative exposures to
low doses of environmental carcinogens. I used the chronic carcinogenesis model as a target
system to investigate the activity of dietary compounds at non-cytotoxic levels in intervention of
cellular carcinogenesis induced by cumulative exposures to pico-molar 4-(methylnitrosamino)-1(3-pyridyl)-1-butanone (NNK) and benzo[a]pyrene (B[a]P). I used various cancer-associated
properties like, reduced dependence on growth factors, anchorage-independent growth, increased
cell mobility, and acinar-conformational disruption as measurable endpoints of carcinogenesis.
The first part (Part-I) of this dissertation focuses on the understanding the breast cancer
progression, importance of environmental carcinogens, role of diet in cancer prevention and
importance of epithelial to mesenchymal transition and stem-like cells in chronic carcinogenesis.
The next three parts (Part II-IV) focus on understanding the role and mechanisms of dietary
compounds in prevention of carcinogenesis and stem-like cell properties. Results in part II
revealed the green tea extract at bio-achievable concentration can suppress carcinogen-induced
cancerous properties. In Part-III, I compared the four major catechins in green tea extract in
suppressing chronic carcinogenesis and the results revealed that epicatechin gallate to be most
vi

effective. I also identified that short-term exposure to NNK and B[a]P resulted in elevation of
reactive oxygen species, ERK pathway activation and induction of cell proliferation and DNA
damage, which can be blocked by green tea catechins. Results in Part-IV describe the roles of
properties and markers associated with stem-like cells and the epithelial to mesenchymal
transition induced by chronic carcinogenesis and their suppression by green tea catechins and
grape seed proanthocyanidin extract. The last section (Part-V) summarizes the findings with their
importance and discusses future directions.
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PART-I

Background and Overview

1

Breast Cancer
According to American Cancer Institute, cancer is a group of diseases that cause cells in
the body to change and grow out of control. Breast cancer begins in breast tissue, which is made
up of glands for milk production, called lobules, and the ducts that connect lobules to the nipple.
The remainder of the breast is made up of fatty, connective, and lymphatic tissue [1]. Breast
cancer (malignant breast neoplasm) is cancer originating from breast tissue, most commonly
from the inner lining of milk ducts or the lobules that supply the ducts with milk. Cancers
originating from ducts are known as ductal carcinomas; those originating from lobules are
known as lobular carcinomas. Breast cancer is the most common type of cancer among women
in northern America and northern Europe. National Institute of Health estimates 230,480
(female); 2,140 (male) new cases and 39,520 (female); 450 (male) deaths from breast cancer in
the United States in 2011 [2]. Worldwide, breast cancer comprises 22.9% of all cancers in
women [3]. Rates of breast cancer around the world vary a great deal, with industrialized
countries generally having higher rates than non-industrialized countries [4] (Figure 1.1).

Stages of Breast Cancer
Staging is the process of determining how much cancer there is in the body and where it
is located. The underlying purpose of staging is to describe the severity and extent of an
individual's cancer, and to bring together cancers that have similar prognosis and treatment [5].
Staging of breast cancer is one aspect of breast cancer classification that assists analyzing
severity and in making appropriate treatment choices.
2

As classified by American Cancer Institute [6] the main stages of breast cancer are (Figure 1.2):
Stage 0 (carcinoma in situ)
This is in situ disease or Paget's disease of the nipple. Stage 0 is a pre-cancerous condition, and is
called carcinoma in situ. There are 2 types of breast carcinoma in situ:
Ductal carcinoma in situ (DCIS) is a noninvasive condition in which abnormal cells are found in
the lining of a breast duct. The abnormal cells have not spread outside the duct to other tissues in
the breast. In some cases, DCIS may become invasive cancer and spread to other tissues,
although it is not known at this time how to predict which lesions will become invasive.
Lobular carcinoma in situ (LCIS) is a condition in which abnormal cells are found in the lobules
of the breast. This condition seldom becomes invasive cancer; however, having lobular
carcinoma in situ in one breast increases the risk of developing breast cancer in either breast.
Stage 1
During stage I, cancer has formed. Stage I is divided into stages IA and IB.
In stage IA: The tumor is 2 centimeters or smaller and has not spread outside the breast.
In stage IB: No tumor is found in the breast, but small clusters of cancer cells (larger than 0.2
millimeters but not larger than 2 millimeters) are found in the lymph nodes.
Stage II
Stage II is divided into stages IIA and IIB.
In stage IIA: No tumor is found in the breast, but cancer is found in the axillary lymph nodes
(lymph nodes under the arm); or the tumor is 2 centimeters or smaller and has spread to the
axillary lymph nodes; or the tumor is larger than 2 centimeters but not larger than 5 centimeters
and has not spread to the axillary lymph nodes.
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In stage IIB: The tumor is either larger than 2 centimeters but not larger than 5 centimeters and
has spread to the axillary lymph nodes; or larger than 5 centimeters but has not spread to the
axillary lymph nodes.
Stage III
Stage IIIA: No tumor is found in the breast. Cancer is found in axillary lymph nodes that are
attached to each other or to other structures, or cancer may be found in lymph nodes near the
breastbone; or the tumor is 2 centimeters or smaller.
Stage IIIB: The tumor may be any size and cancer has spread to the chest wall and/or the skin of
the breast; and may have spread to axillary lymph nodes that may be attached to each other or to
other structures or cancer may have spread to lymph nodes near the breastbone.
Cancer that has spread to the skin of the breast is inflammatory breast cancer.
Stage IV
Stage IV describes invasive breast cancer that has spread beyond the breast and nearby lymph
nodes to other organs of the body, such as the lungs, distant lymph nodes, skin, bones, liver, or
brain. This is the metastatic stage.

Risk factors for Breast cancer
A risk factor is anything that increases a person's chance of getting a disease. Different
cancers have different risk factors. As stated by Breast Cancer Organization [7], there are some
known risk factors for breast cancer (Figure 1.3). Just being a woman is the biggest risk factor
for developing breast cancer. There are about 190,000 new cases of invasive breast cancer and
4

60,000 cases of non-invasive breast cancer this year in American women. As with many other
diseases, risk of breast cancer goes up with age. About two out of three invasive breast cancers
are found in women 55 or older.
Women with close relatives who've been diagnosed with breast cancer have a higher risk
of developing the disease having one first-degree female relative (sister, mother, daughter)
diagnosed with breast cancer, doubled the risk. About 5% to 10% of breast cancers are thought to
be hereditary, caused by abnormal genes passed from parent to child. Radiation exposure to the
chest to treat another cancer, such as Hodgkin's disease or non-Hodgkin's lymphoma, also
increases the average risk of breast cancer. Being diagnosed with certain benign breast
conditions also increases risk of breast cancer. Caucasian women are slightly more likely to
develop breast cancer than African-American, Hispanic, and Asian women. But AfricanAmerican women are more likely to develop more aggressive, more advanced-stage breast
cancer that is diagnosed at a young age.
Overweight and obese women have a higher risk of being diagnosed with breast cancer
compared to women who maintain a healthy weight, especially after menopause. Being
overweight also can increase the risk of the breast cancer recurrence in women who have had the
disease. Other risk factors include using HRT (Hormone Replacement Therapy), drinking
alcohol, lack of exercise and smoking.
Studies show that only 3-10% breast cancer is genetic, more that 85% is non-genetic
breast cancer caused by environmental factors [8], so it is important to study and understand the
role of such environmental factors in breast cancer development
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Environmental Carcinogens
Environmental carcinogens are defined as any of the natural or synthetic substances that
can cause cancer. Humans are subjected to a range of chemical exposures from the environment.
Chemicals in air, water, soil and food, occupational exposures and lifestyle factors, all contribute
to a complex exposure situation in our daily life [9]. More that 90% are non-hereditary or
„sporadic‟ cancers [8]. Considering the importance of chronic exposure of human tissues
environmental carcinogens in causing most sporadic human cancers, it is imperative to study,
understand and prevent the factors associated with causing sporadic cancers.

According to the American Cancer Society [10] some of the non-hereditary potential
cancer-causers (Figure 1.4) can be classified as following:


Related to lifestyle (smoking, alcohol, diet, being sedentary)



Naturally occurring substances (ultraviolet rays, infectious agents, radon)



Chemicals in the home and workplace



Medical treatments (hormone replacement, immune-suppressing treatments)



Others

Related to lifestyle
Most of the lifestyle-related factors are not by themselves cancer causing agents, but are
risk factors associated with the genesis of cancer, but occupational exposures, behavior-related
habits and addiction can lead to exposure to higher dose of carcinogens [11]. It is well agreed
that smoking and to a lesser extent alcohol consumption, diet imbalance, obesity and lack of
physical exercise can contribute to cancer in high-income countries [11].
6

Tobacco smoking
Smoking is indeed a serious concern, and a major risk factor contributing to human
carcinogenesis in multiple organs [12]. Tobacco smoke contains thousands of compounds
including many mutagens such as polycyclic aromatic hydrocarbons and nitrosamines and as
well as other promoters. Therefore this mixture constitutes the equivalent of what is defined as a
complete carcinogen [13]. As shown by multiple studies, smoking is a risk factor for several
types of cancers, mainly lung cancer and cancers of the upper aero digestive tract, and also, to a
certain extent, for esophagus, stomach, pancreas, liver, bladder, kidney, mammary and cervical
cancers, as well as myeloid leukemia [12,14]. Because many of these cancers are associated with
a poor prognosis, smoking remains a major cause of cancer mortality.
Alcohol consumption
Ethyl alcohol is not per se a mutagenic agent for DNA, but rather acts mainly as a cocarcinogen. On the basis of epidemiological data, alcohol has been classified as a human
carcinogen [15]. Studies have shown that alcohol can potentiate the carcinogenic effects
associated with smoking or other related risk factors [16], but overall its action is not clear.
Diet
Several studies have shown that in developed countries, food intake imbalance which is
rich in calories and animal fat and low in fiber, is a factor that leads to the occurrence of some
cancers (colon, prostate, endometrium and breast) and conversely a high intake of fruits and
vegetables with high antioxidant contents have a protective anticancer effect [17,18]. A very
important dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is one of
the most mass-abundant heterocyclic amines, which are a group of mutagenic compounds
7

particularly found in high-temperature cooked meats, such as grilled/barbecued meats [19-21].
Epidemiological studies indicate that consumption of well-done meats containing PhIP may play
an important role in the risk of breast and other cancers [22].
Overweight, obesity and sedentary lifestyle
Overweight, obesity and sedentary lifestyle have been incriminated as risk factors for
cancer [23, 24]. Studies in the USA have suggested that obesity associated with some cancers
can worsen cancer mortality [25]. An According to American Institute for Cancer Research study
where they looked at seven cancers with known links to obesity and calculated actual case counts
that were likely to have been caused by obesity. The results showed that 49% of endometrial
cancers are associated to excess body fat. That number is followed by 35% of esophageal cancer
cases; 28% of pancreatic cancer cases; 24% of kidney cancer cases; 21% of gallbladder cancer
cases; 17% of breast cancer cases; and 9% of colorectal cancer cases [26].

Naturally occurring substances
Ultraviolet rays
Though most forms of radiation have not been linked to cancer, there is evidence that
certain types of radiation, such as ionizing and ultraviolet, can damage DNA and cause cancer.
UV irradiation is one of the most relevant risk factors for the development of skin cancer [2729]. The UV-induced tumors show a rapidly rising incidence not only in the United States but
also in Europe and in Australia [30].
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Infectious agents
Research indicates that 15 to 20 % of worldwide cancer cases are related to infections
caused by viruses, bacteria and parasites [31]. Some infections can cause inflammation, which
may suppress a person‟s immune system or directly affect a person‟s DNA. Bacteria such as H.
pylori implicated in a greater risk for stomach cancer [32] and viruses such as HPV linked to
cervical cancer [33] can increase risk for developing cancer.
Radon
Radon, a colorless, odorless, radioactive gas, is among the best studied of environmental
carcinogens. It is found in soil and rock, outdoors and indoors, with the highest levels in
basements, where radon leaks through cracks or gaps in floors or walls. High levels of radon
have been linked to lung cancer [34]. These high levels can occur when radon becomes
concentrated in an area and cannot dissipate. Exposure to radon is the second leading cause of
lung cancer, after smoking. In the US, radon causes about 21,000 lung cancer deaths every year
out of a total of about 160,000 annual lung cancer deaths [35].

Chemicals in the home and workplace
According to National Institute of Environmental Health Sciences, any substances and
circumstances that are "known" or are "reasonably anticipated" to cause cancer are considered
chemical carcinogens. A large number of chemicals are considered carcinogenic. The list
includes benzene, auto exhaust, cigarettes, industrial processes and some consumer goods, which
have been linked to various types of cancers. Many other environmental substances are
potentially carcinogenic and under study to determine their level of cancer-causing potential as
9

listed by the Environmental Protection Agency and American Cancer Society [36]. A few
important chemical carcinogens are discussed in detail here.
Diesel exhaust: A contributor to air pollution has been classified as an environmental
carcinogen [37] and is most associated with an increased risk of lung cancer. It is given off by
vehicles, construction and farm equipment with diesel engines [38]. The people with the highest
exposure are at the greatest risk of developing cancer [39].
Secondhand smoke: Also known as passive smoke, secondhand smoke contains more
than 4,000 chemical compounds, with more than 60 of these compounds known or suspected to
cause cancer [40]. Secondhand smoke is most dangerous in enclosed places, such as home, car,
workplace and public buildings where smoking indoors is allowed. Secondhand smoke exposure
has been shown to be associated with increasing incidences of lung and other types of cancer
[41].
Asbestos: found in older buildings, increases the risk of lung, malignant mesothelioma of
the pleura and peritoneum, cancer of the larynx, and certain gastrointestinal cancers [42]. The
total deaths in US due to asbestos-related lung cancer, mesothelioma and asbestosis from
workplace exposure resulted is estimated to be over 200,000 for year 2010 [43]. In addition,
several thousands of deaths can be attributed to other asbestos-related diseases, as well as to nonoccupational exposures [44].

Medical treatments (hormone replacement, immune-suppressing treatments)
Hormone replacement therapy (HRT) has been used extensively in postmenopausal
women as a proven and effective therapy for climacteric symptoms and in osteoporosis
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treatment. Its widespread long-term use for indications such as primary prevention of
cardiovascular disease or cognitive decline was called into question with the publication of
several epidemiological studies [45]. The risk of breast cancer varies with the formulation and
preparation of HRT. Opposed estrogens (progesterone–estrogen) in oral form are associated with
an increased risk of breast cancer, which increases with use [46]. HRT has also shown to cause
increased risk of ovarian [47], colorectal [48], brain [49] and other types of cancer.
Immunosuppressive mediations are essential to prevent graft rejection and to optimize
graft survival. However, because these medications suppress the immune system, whose main
function is to fight off infection and prevent the development of cancer, transplant recipients are
at elevated risk for infection and certain cancers [50, 51]. The exact mechanism by which
immunosuppressive medications promote tumor growth is currently being studied. However,
several lines of evidence suggest the duration, intensity and type of immunosuppressant may be
related to the development of skin cancer [52], lymphoma [53] and some other types of cancer.
The risk of cancer with these treatments greatly depend on the dose, therefore talking to the
doctors before starting such therapies is the best way to understand the personal risk of cancer.
Others
There are many other environmental factors which have and can cause cancers.
Environmental Protection Agency report, based on emissions data from 2002, estimates the local
and regional concentrations of 181 different air pollutants from vehicles and industrial
contaminants; as well as other sources [54]. Particulate materials that cause cancer include
powdered metallic cobalt and nickel, and crystalline silica (quartz, cristobalite, and tridymite)
[55]. According to International Agency for Research on Cancer [56] other carcinogens included,
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antiperspirants, talcum powder, hair dyes, cosmetics as well as food products have shown to be
potential carcinogens [57], but the exposure to most of the chemicals is needed to be at
occupational level to show significant affect [58]. The use of chemicals at home and work place
should be monitored and used only as needed for reducing the risk of excessive exposure to
them.

This classification of various environmental carcinogens is only indicative, as many other
factors may play role in cancer development.
In this study, the impact of two environmental carcinogens was of interest, 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a]pyrene (B[a]P) as affecting
breast cancer. These carcinogens are discussed in detail in following sections.
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4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
Carcinogenic transformation of breast cells from non-cancerous to precancerous and
cancerous stages is a multiyear, multistep, and multipath disease process with progressive
genetic and epigenetic alterations [59, 60]. Although numerous factors have been postulated to
contribute to breast cancer, more than 85% of breast cancers are attributable to environmental
factors, such as exposures to chemical carcinogens, dietary habits, etc. [61-68]. Growing
evidence indicates exposures to tobacco and environmental carcinogens may increase the risk of
sporadic human breast cancer [59, 63–70]; however, the role of tobacco and environmental
carcinogens in the development of human breast cancer is still not clear. Possibly, the nature of a
long-term, accumulative exposure to tobacco and environmental carcinogens plays an important
role in the progressive development of human breast cancers. Thus, it is important to understand
the ability of tobacco and environmental carcinogens to chronically transform breast epithelial
cells in order to clarify their roles in the development of human breast cancer.
Nicotine-derived nitrosamine ketone (NNK), or 4-(methylnitrosamino)- 1-(3-pyridyl)-1butanone (Figure 1.5a), is a nitrosamine present in tobacco that is a potent pro-carcinogen. The
tobacco specific carcinogen NNK, one of the most potent carcinogens in tobacco products,
induces a high incidence of pulmonary cancers but no breast cancer in laboratory rodents
[71,72]. The formation of DNA-adducts from reactive NNK metabolites causes activating point
mutations of genes, such as the Ki-ras gene that is frequently observed in human lung cancer
cells [71,72]. Recently, Zimmerman‟s groups have indicated an interchangeable conversion
between NNK and its metabolites, suggesting a novel persistent activity for NNK [73]. NNK
also acts as a potent agonist for β-adrenergic receptors and α7-nicotinic acetylcholine receptors
13

and stimulates arachidonic acid-dependent and Erk-dependent mitogenic pathways associated
with these receptors [74-78]. Other studies have shown alterations in the cell cycle machinery
including cyclin D1, cdk4, p16INK4a, and Rb, contributing to the acquisition of autonomous
growth by NNK-induced tumors [79]. However, the association between smoking and breast
cancer is still controversial; some studies have indicated there is no influence of smoking on
breast cancer incidence [80], and some studies have shown a correlation between them [81].
Recently, a study was conducted by four major Canadian agencies to address this controversy,
and the results indicate that active smoking and second-hand smoke increase breast cancer risk
[82]. Another recent cohort study in the United States has also shown a connection between
smoking and breast cancer in postmenopausal women [83]. Thus, the role of smoking in
increasing the incidence of breast cancer should be taken seriously.

Benzo[a]pyrene (B[a]P)
Benzo[a]pyrene (B[a]P), C20H12, is a five-ring polycyclic aromatic hydrocarbon (Figure
1.5b) whose metabolites are mutagenic and highly carcinogenic. B[a]P is listed as a Group 1
carcinogen by the IARC [14]. B[a]P is found in coal tar, in automobile exhaust fumes (especially
from diesel engines), in all smoke resulting from the combustion of organic material (including
cigarette smoke), and in charbroiled food. Cooked meat products, regular consumption of which
has been epidemiologically associated with increased levels of colon cancer [84] (although this
in itself does not prove carcinogenicity)[85], have been shown to contain up to 4 ng/g of
benzo[a]pyrene,[86] and up to 5.5 ng/g in fried chicken[87] and 62.6 ng/g in overcooked
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charcoal barbecued beef.[88]. Therefore B[a]P is considered a tobacco, environmental, and
dietary chemical carcinogen [89-93].
B[a]P intercalates in DNA, covalently bonding to the nucleophilic guanine nucleobases at
the N2 position. X-ray crystallographic and nuclear magnetic resonance structure studies show
that this binding distorts the DNA [94], inducing mutations by perturbing the double-helical
DNA structure. This disrupts the normal process of copying DNA and induces mutations, which
explains the occurrence of cancer after exposure. This mechanism of action is similar to that of
aflatoxin which binds to the N7 position of guanine [95].
B[a]P has been identified as a mammary carcinogen in rodents [96-98]. Studies have
indicated that B[a]P contributes to the development of human breast cancer because its
metabolites form strong DNA-adducts that cause DNA lesions [99-102]. However, PAH-derived
DNA-adducts alone are insufficient for inducing human breast cancer [59, 99, 102]. Thus, B[a]P
may play an important role in precancerous carcinogenesis of human breast cells. The most
widely identified precancerous stage of breast cancer is ductal carcinoma-in-situ (DCIS).
Although DCIS cells have not developed the ability to invade out of the ducts or lobules and
metastasize, those cells can develop into and raise the risk of invasive breast cancers [59, 103,
104]. So it is important to identify the role of carcinogens in early precancerous stages of cancer
progression in the hope that it will provide better prognosis of the disease and better chance to
prevent its progression.
Therefore, further studies are needed to conclusively identify NNK and B[a]P as potent
carcinogens in the development of mammary carcinogenesis, especially during the early stages.

15

Precancerous Model of Cancer Progression
Growing evidence indicates that exposure to environmental carcinogens may increase the
risk of sporadic human breast cancer. To address the question of whether NNK and B[a]P are
able to induce cellular transformation of human breast epithelial cells, we have taken the
approach of mimicking chronic exposure of cells to tobacco and environmental carcinogens by
repeated treatments of the non-cancerous human breast epithelial MCF10A cell line with NNK
and B[a]P at picomolar concentrations, which mimics doses commonly detected in smokers
[105-107]. We have been testing a cellular model that is able to reveal the potency of an
environmental carcinogen to induce chronic carcinogenesis of breast cells to progressively
acquire identifiable cancer-related properties, mimicking long-term exposure of breast cells to
low doses of an environmental carcinogen. Using this model we repeatedly exposure
immortalized, noncancerous, human breast epithelial MCF10A cells to B[a]P and/ or NNK)at
picomolar concentrations, which results in induction of cancer-related cellular properties [108112]. This model aims to mimic the chronic exposure to tobacco and environmental carcinogens
that are encountered by human on a day to day basis. This model also highlights the importance
and relevance of “pre-cancerous” stage for cancer prevention target, rather than the therapeutic
approach for malignant cells. Also it helps to qualify the utilization of MCF10A cell line to
qualitatively and quantitatively study cancer progression in early stages of human breast
epithelial cells.
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Detection of Cancer Progression
Reduced dependence on growth factors
A lack of growth factors causes normal cells to become growth-arrested in the cell cycle
and to commit apoptosis; however, aberrantly increased cell survivability acquired to reduce
dependence on growth factors can lead cells to tumorigenic transformation [109-112]. Cancer
cells do not need stimulation from external signals (in the form of growth factors) to multiply.
Normal cells require external growth signals (growth factors) to grow and divide. These signals
are transmitted through receptors that pass through the cell membrane. When the growth signals
are absent, normal cells stop growing, but cancerous cells can grow and divide without external
growth signals.

Anchorage-independent growth
Cell adhesion to extracellular matrixes is important for cell survival in a multicell
environment; aberrantly increased cell survivability acquired to promote anchorage-independent
growth can promote tumorigenic transformation [113, 114]. The cellular transformation is
associated with certain phenotypic changes such as loss of contact inhibition (cells can grow over
one another) and anchorage independence (cells form colonies in soft agar). Anchorage
independence can be described in the light of primary fibroblasts and many fibroblastic cell lines
(e.g. BALB/c3T3, NIH-3T3, etc.) that must attach to a solid surface before they can divide [114].
They fail to grow when suspended in a viscous fluid or gel (e.g. agar or agarose), however when
these cell lines are transformed, they are able to grow in a viscous fluid or gel and become
anchorage-independent. The ability to grow on "soft agar" is a routine test taken as an indication
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that cells with this ability are anchorage independent. Anchorage-independence correlates
strongly with tumorigenicity and invasiveness in several cell types, such as small-cell lung
carcinoma [115-117].
Acquisition of Acinar-Conformational Disruption
Acinar structures with a hollow lumen and apicobasally polarized cells are important
characteristics found in glandular epithelia in vivo; the disruption of an intact glandular structure
is a hallmark of epithelial cancer even at precancerous stages such as DCIS [118, 119]. Parental
MCF10A cells mainly form regular, round spheroids on Matrigel cultures, and NNK-and B[a]Pexposed cells form both regular and irregular spheroids, whereas cancerous MCF-7 cells only
form irregular spheroids.
Wound Healing
Cancerous cells acquire an increased mobility compared with their normal counterpart
cells [120]. When wounded or scratched, cell monolayers respond to the disruption of cell-cell
contacts and an increased concentration of growth factors at the wound margin by healing the
wound through a combination of proliferation and migration [121-123]; these processes reflect
the behavior of individual cells as well as the properties of increased motility. Cancer cells can
move through tissues in a variety of different ways. In some cases, an epithelial-to-mesenchymal
transition enables cancer cells to acquire fibroblast-like migratory properties. However, it is also
becoming apparent that some cancer cells move in an amoeboid way similar to leukocytes
[120].Thus increased mobility is a hallmark characteristic of cancerous cells.
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Migration and Invasion
The ability of a cancer cell to undergo migration and invasion allow it to change position
within the tissues. For example, these processes allow neoplastic cells to enter lymphatic and
blood vessels for dissemination into the circulation, and then undergo metastatic growth in
distant organs [125]. The capability for invasion and metastasis enables cancer cells to escape the
primary tumor mass and colonize new terrain in the body where, at least initially, nutrients and
space are not limiting. The acquired capability for invasion and metastasis represents the last
great frontier for exploratory cancer research [126]
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Role of ERK Pathway in Cancer
Mitogen-activated protein kinase (MAP kinase) cascades transmit and amplify signals
involved in cell proliferation as well as cell death. These signal transduction pathways serve as
an indicator of the intensity of trafficking induced by various growth factors, steroid hormone,
and G protein receptor mediated ligands. Three major MAP kinase pathways exist in human
tissues, but the one involving ERK-1 and -2 is most relevant to breast cancer [128]. The
Ras/Raf/MEK/ERK cascade couples signals from cell surface receptors to transcription factors,
which regulate gene expression and cell cycle progression [129].
ERK Pathway: Binding of growth factors to receptor tyrosine kinases stimulates the
autophosphorylation of specific tyrosines on the receptors. The phosphorylated receptor then
binds to an adaptor protein called GRB2 which, in turn, recruits SOS (son of sevenless) to the
plasma membrane. SOS is a guanine nucleotide exchange factor which displaces GDP from Ras,
subsequently allowing the binding of GTP. GTP-bound Ras recruits and activates Raf. Raf
initiates a cascade of protein phosphorylation by first phophorylating MEK. Phosphorylated
MEK in turn phosphorylates ERK. Phosphorylated ERK moves from the cytoplasm into the
nucleus where it subsequently phosphorylates a number of transcription factors, including the
specific transcription factor called Elk-1. Phosphorylated transcription factors turn on
transcription (gene expression) of specific sets of target genes. The activity of Ras is limited by
the hydrolysis of GTP back to GDP by GTPase activating proteins (GAP) [129] (Figure 1.6).
Sivaraman et al. [130] provided the first demonstration of MAP kinase activation in
human breast cancer tissues. They compared primary breast cancers with benign tissues using
substrate based MAP kinase enzyme assays as well as western blotting methods. All 11 breast
cancers had markedly elevated levels of activated MAP kinase. Salh et al. [131] examined 23
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human breast cancers by substrate enzyme assay as well as by immunologic techniques. Over
expression of both ERK-1 and -2 were demonstrated with use of specific antibodies.
Immunoprecipitation studies with anti-activated ERK antibodies demonstrated up to a 2.5-fold
increase in activated MAP kinase in breast cancers. However, elevations were only seen in 50%
of tumors. Mueller et al. [132] studied 131 breast cancers and 18 normal tissues adjacent to
tumors. They reported enhanced activation of MAP kinase in a subset of tumors. There was a
trend for higher MAP kinase activity in primary tumors of node positive patients than in those
from node negative patients. Activated MAP kinase demonstrated a trend to be predictive of
disease free survival. Another study [133] investigated the mechanisms for up-regulation of
MAP kinase in breast tumors. They found elevated activated MAP kinase in 11/20 cancers.
These data suggest that if the appropriate receptors are present, upregulation of ligands may be
responsible for MAP kinase increases in human breast cancers. This possibility is supported by
the in vitro studies of Xing and Imagawa [134] who demonstrated that EGF could increase
activated MAP kinase in primary cultures of mouse mammary cells. These studies, taken
together, suggest that further correlation of activated MAP kinase with the biologic
characteristics of tumors is now warranted [128]. Studies show that high dose exposure to
environmental carcinogens lead to ERK pathway activation [135], but whether low dose of
environmental carcinogens can induce ERK pathway in breast cancer needs to be evaluated.
Further work will be needed to assess the importance of measuring MAP kinase in human breast
cancer tissue.
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Role of Reactive Oxygen Species in Cancer
Reactive oxygen species (ROS) are oxygen containing chemical species with reactive
chemical properties generated inside the cell as the consequence of respiration and enzymatic
activities. ROS include O2-derived free radicals such as superoxide anion radical (O2-) and the
hydroxyl radical (·OH), which contain an unpaired electron, and nonradical derivatives of O2
such as hydrogen peroxide (H2O2) [136, 137]. Chemical and physical agents that produce ROS
can induce and/or modulate the multistep carcinogenesis process [138]. Recent studies have
shown an important role for reactive oxygen species in tumor development [139, 140]. Oxidative
stress may cause DNA, protein, and/or lipid damage, leading to changes in chromosome
instability, genetic mutation, and/or modulation of cell growth that may result in cancer.
ROS can be produced from endogenous sources, such as from mitochondria,
peroxisomes, and inflammatory cell activation; and exogenous sources, including environmental
agents, pharmaceuticals, and industrial chemicals [138]. Various environmental agents like,
chlorinated compounds, radiation, metal ions, barbiturates, phorbol esters, acrylonitrile, and
some peroxisome-proliferating compounds have been shown to induce oxidative stress and
damage in vitro and in vivo studies [141]. Mutation studies have suggested that chronic oxidative
stress is associated with carcinogenesis. Oxidative DNA damage is a major source of the
mutation load in living organisms, with more than one hundred oxidative DNA adducts (purine,
pyrimidine, and the deoxyribose backbone) having been identified [ 142-145]. The estimated
frequency of oxidative DNA damage in human cells is 104 lesions/ cell/ day [142, 146]. High
dose exposure to carcinogens has been shown to induce ROS in some studies [147], but the
effect of low dose environmental carcinogens in ROS production still needs to be validated. Also
how ERK pathway and ROS roles in carcinogenesis need to be investigated.
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Stem Cells and Cancer
According to the most widely accepted views, stem cells are the cells that can “selfrenew” to produce more cells and to generate daughter cells that can differentiate to several
lineages to form all cell types found in a tissue. The stem cells might undergo a special kind of
cell division where each stem cell divides into two asymmetric cells, one of which is
differentiated to various types of cells and the other retains the capability of being the stem cells,
renewing the stem cell pool of the body by further asymmetric division [148, 149]. In this
process the number of stem cells remains constant. The other defining property of stem cells is
“potency” to different types of specialized cells. Stem cells can either be totipotent or pluripotent
- to be able to give rise to any mature cell type, although multipotent or unipotent progenitor
cells are sometimes also referred to as stem cells.
Types of stem cells
Two broad types of mammalian stem cells are:
1. Embryonic stem cells: Embryonic stem cells (ES cells) are stem cells derived from the
inner cell mass of an early stage embryo known as a blastocyst [150].
2. Adult stem cells: Adult stem cells are undifferentiated cells, found throughout the body
after embryonic development that multiply by cell division to replenish dying cells and
regenerate damaged tissues. They are of various types depending on source organ:
(a) Haematopoietic stem cells are found in the bone marrow and give rise to all the blood
cell types [151].
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(b) Mammary stem cells provide the source of cells for growth of the mammary gland
during puberty and gestation and play an important role in carcinogenesis of the breast
[152].
(c) Mesenchymal stem cells (MSCs) are of stromal origin and may differentiate into a
variety of tissues. MSCs have been isolated from placenta, adipose tissue, lung, bone
marrow and blood and Wharton's jelly from the umbilical cord [153].
(d) Neural stem cells are commonly cultured in vitro as so called neurospheres- floating
heterogeneous aggregates of cells, containing a large proportion of stem cells [154].
(e) Olfactory adult stem cells have been successfully harvested from the human olfactory
mucosa cells, which are found in the lining of the nose and are involved in the sense of
smell [155].
(f) Dental pulp derived stem cells: Multipotent stem cells known as SHED cells (Stem
cells Harvested from Exfoliated Deciduous teeth), have been shown to have the same
cellular markers and differential abilities of mesenchymal stem cells.
(g) Testicular cells are multipotent stem cells with a claimed equivalency to embryonic
stem cells have been derived from spermatogonial progenitor cells found in the
testicles.
Cancer Cell
Cancer develops from normal cells that have gained the ability to aberrantly proliferate
and lost the ability of growth check points [113]. Some key characteristics of cancer cells are:
Uncontrolled growth: The cancer cells divide in an uncontrolled manner and often are called
„immortal‟.
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Override cellular signals: The cancer cells escape the signaling that control and organizes the
growth and differentiation of normal cells.
Contact inhibition: They can grow as solid mass, rather than layers.
Undifferentiated: Cancers are mass of undifferentiated cells, which do not form any tissue, just
divide uncontrollably.

Models for cancer progression:
Stochastic model predicts that every cancer cell has the potential to form a new tumor,
but entry into the cell cycle is a stochastic event that occurs with low probability. The stochastic
model postulates that the processes of self-renewal versus differentiation in single cells within a
population occur randomly and are governed by probabilities. Accordingly, every tumor cell
will have a low but equal probability of proliferating extensively and thus the potential to
behave as a stem cell (Figure 1.7a). Importantly, only those cells that retain self-renewal
capacity would have the ability to sustain neoplastic growth [156-158]. Under the assumptions
that all cancer cells have similar potential to grow tumors and that tumors are usually clonal in
origin, it can be expected that even a few cancer cells would be able to grow new tumors

Stem cell model proposes the existence of distinct classes of cells within a tumor, each
with different capacities for self-renewal and proliferation. Consequently, only a small definable
subset of cells will consistently have the capacity to initiate tumor growth and reproduce the
hierarchy of cell types that comprise the tumor [157, 159, 160] (Figure 1.7b).
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Cancer Stem Cell
More and more recent studies are strengthening the importance and role of stem cells in cancer
progression (Figure 1.8).
Evidences for the cancer stem cell hypothesis:
1. Most of the mutations leading to cancer affect cellular machinery that controls cell
division, DNA damage, and signal transduction pathways. Stem cells may be preferential
targets of initial oncogenic mutations because in most tissues in which cancer originates
they are the only long-lived populations and are therefore exposed to more genotoxic
stresses than their shorter-lived, differentiated progeny [148, 156].
2. Most tumors arise from a single cell, but not all the cells within a tumor are identical.
This concept is also known as tumor heterogeneity [161].
3. A large number of cancer cells were required to grow a tumor. These observations were
seemingly at odds with the traditional stochastic model of cancer development [148].
4. Both recent and traditional therapies suggest that in most cases tumor always re grow, no
matter how often the tumor mass is reduced [148].
5. Stem cells often persist for long periods of time, instead of dying after short periods of
time like many mature cells in highly proliferative tissues. This means that there is a
much greater opportunity for mutations to accumulate in individual stem cells than in
most mature cell types [148, 161]
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Breast Cancer and Mammary Stem Cells
The mammary gland in humans and other mammals is a dynamic organ that undergoes
significant developmental changes during pregnancy, lactation, and involution.
The basic components of a mature mammary gland are the alveoli (hollow cavities) lined with
milk-secreting cuboidal cells and surrounded by myoepithelial cells. These alveoli join up to
form groups known as lobules, and each lobule has a lactiferous duct that drains into openings in
the nipple. During pregnancy and lactation lobulo-acinar structure containing milk secretion
alveolar cells are extensively formed (Figure 1.9). After lactation the organ goes through
massive apoptosis and tissue remodeling to go back to normal form [162, 163]. So the mammary
gland is a dynamic tissue and it should have some progenitor cells to sustain the proliferation
during pregnancies.
Decades ago, Daniel et al [164] showed that complete mammary gland can be generated
from random epithelial fragments. Recently, Shackleton et al [165] have shown that entire
mammary gland can be generated using a single mammary “stem cell”. So it is beyond doubt
now that mammary gland is a source of adult stem cells in the body.
The isolation and characterization of mammary stem cells have been hindered because of two
reasons, firstly, the scarcity of suitable markers and secondly, lack of suitable systems to
maintain the stem cells in undifferentiated state [161].
Pioneering work by Al-Hajj et al [159], lead to identification of tumorigenic mammary
stem cell markers. Cells expressing CD44+ CD24-/low Lineage- have been shown to have ability to
form complete tumor when injected into mice at low numbers like 100. Major advancement in
culturing neural stem cell was achieved when they were grown as anchorage independent
colonies in suspensions under low serum conditions, creating spheroids called neurospheres
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[166]. A similar approach was used to grow mammary gland stem cells in suspensions as well,
and these non-adherent spherical colonies were called “Mammospheres” [167].

Identification and Isolation of Mammary Stem Cells
With the recent advancement in stem cell research, it is now possible to identify and
isolate mammary stem cells at better efficiency than before. There are various markers and
characteristics that make them different from the surrounding differentiated cells.
Mammospheres
It is know that normal epithelial cells are anchorage dependent and they undergo anoikis,
a special type of apoptosis that occurs when the cells are detached from extra cellular matrix,
when grown in substratum-less conditions [168]. Undifferentiated multi-potent population of
cells can be grown in suspension as mammospheres [167]. The mammospheres are enriched in
stem cells or progenitor cells. After several passaging the number of stem cells if highly
enriched, after four passages the mammosphere consists mostly of stem cells.
ALDH Activity
Ginestier et al [169] showed that normal and cancer human mammary epithelial cells
with increased aldehyde dehydrogenase activity (ALDH) has stem/progenitor properties. These
cells contain the subpopulation of normal breast epithelium with the broadest lineage
differentiation potential and greatest growth capacity in a xenotransplant model. Aldehyde
dehydrogenase is a polymorphic enzyme responsible for the oxidation of aldehydes to carboxylic
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acids. These findings offer an important new tool for the study of normal and malignant breast
stem cells and facilitate the clinical application of stem cell concepts [169]
Immunostaining
Like the other type of adult stem cells, mammary stem cells also have been identified
using cell surface markers. Mammary SCA-1 (Stem Cell Antigen-1) has been used to identify
the stem cells [170]. The immune-staining and cell sorting using surface markers is a very widely
used technique to enrich the stem cell population. Breast cancer stem cells have also been
identified with cell surface markers, CD44+ CD24-/low Lineage- which are seen to be over
expressed in breast tumor cells [159].
Extensive self-renewal and multi lineage differentiation
Stem cells can generate the entire repertoire of cell types found in a tissue. The stem cells
derived from the mammospheres have the capacity to self-renew for extended number of times.
Also the stem cells can differentiate into various types of cells; when they are grown on collagen
substratum under differentiating conditions, like in 2D culture systems, matrigel or in presence
of prolactin. Under these conditions the stem cells differentiate in to alveolar, acinar or ductal
structures [161].
Dye exclusion ability
Stem cells, including neural, hematopoietic and mammary, have a characteristic property
to exclude dyes such as rhodamine and Hoechst [171] as a result of increased expression of
membrane transporter proteins, such as P-glycoproteins or BCRP (breast cancer resistance
proteins). This unique dye exclusion property is because of ATP-binding cassette family of
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transporter proteins, which pump outs the dye. This population of cells which has dye exclusion
property is called “Side population” and it is generally enriched in stem cell surface markers.
Label retention ability
Several studies have shown that a sub-set of cells have the capacity to retain the label like
BrdU or H3-tymidine, these are designated as label retaining cells (LCR). Various studies have
shown that very few of these LCR cells express differentiation markers and suggest that they are
in less differentiated state and may be progenitor cells [170]. BrdU is incorporated in the DNA
and gets diluted as the cells divides and is lost after certain number of divisions, long term
maintenance of the label shows that the cells have a low proliferation rate that helps them to
survive for much longer time than normal cells.
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Epithelial to Mesenchymal Transition
The epithelial-mesenchymal transition (EMT) is an orchestrated series of events in which
cell-cell and cell-extracellular matrix (ECM) interactions are altered to release epithelial cells
from the surrounding tissue, the cytoskeleton is reorganized to confer the ability to move through
a three-dimensional ECM, and a new transcriptional program is induced to maintain the
mesenchymal phenotype [172]. For example, during early embryonic development, the
mesoderm generated by EMTs develops into multiple tissue types, and later in development,
mesodermal cells generate epithelial organs, such as the kidney and ovary, via Mesenchymal to
Epithelial transition (MET) [173, 174]. Turning an epithelial cell into a mesenchymal cell
requires alterations in morphology, cellular architecture, adhesion, and migration capacity.
Through EMT, the polarized epithelial cell, which normally interacts with basement membrane
via its basal surface, undergoes multiple biochemical changes that enable it to assume a
mesenchymal cell phenotype, which includes enhanced migratory capacity, invasiveness,
elevated resistance to apoptosis, and greatly increased production of ECM components [175]
Molecular markers associated with EMT include increased expression of N-cadherin and
vimentin, nuclear localization of β-catenin, and increased production of the transcription factors
such as Snail1 (Snail), Snail2 (Slug), Twist, EF1/ZEB1, SIP1/ZEB2, and/or E47 that inhibit Ecadherin production. Phenotypic markers for an EMT include an increased capacity for
migration and three-dimensional invasion, as well as resistance to anoikis/apoptosis [176]
(Figure1.10). A summary of common EMT markers is listed in Table 1.1 [176].
Induction of EMT has been shown to be highly tissue- and cell type-specific [177],
because factors that induce EMT under some conditions and locations can have quite different
effects in others [178]. Some of the cytoplasmic signal transduction pathways are fairly well
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defined - for example, the activation and nuclear translocation of SMAD proteins following
association of TGF-β with its cell surface receptors [179]. In other cases, activation of EMT
involves more pleiotropic signals, as in the case of reactive oxygen species (ROS) produced in
response to exposure to matrix metalloproteinases (MMPs) [172]. Several other oncogenic
pathways like, peptide growth factors, Src, Ras, Ets, integrin, Wnt/beta-catenin and Notch may
induce EMT [180]. In particular, Ras-MAPK has been shown to activate two related
transcription factors known as Snail and Slug. Both of these proteins are transcriptional
repressors of E-cadherin and their expression induces EMT [181]. Recently, some studies have
shown activation of the phosphatidylinositol 3' kinase (PI3K)/AKT axis is emerging as a central
feature of EMT [182] (Figure 1.11).

EMT and Cancer Stem Cell
During cancer progression, some cells within the primary tumor may reactivate the latent
embryonic program of EMT. Through EMT, transformed epithelial cells can acquire the
mesenchymal traits that seem to facilitate metastasis but, there is accumulating evidence that
EMT and mesenchymal-related gene expression are associated with aggressive breast cancer
subtypes and poor clinical outcome in breast cancer patients. EMT along with play a key role in
normal embryo developmental processes has also been shown to play role during cancer invasion
and metastasis [174]. Also, recently EMT has shown to generate cells with stem cells properties
[174]. Developmental hierarchy has been demonstrated in breast tissue where, stem cells give
rise to both the outer myoepithelial layer and the inner layer of luminal epithelial cells, which
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define the bilayered architecture of the branching mammary gland [183-185]. Normal human
mammary tissue contains a subpopulation of EpCamhigh/CD49fhigh stem cells that give rise to
mammospheres and to bilayered, branching structures in 3D culture [172, 185]. Recently, Mani
et al reported that the induction of an EMT in immortalized human mammary epithelial cells
(HMLEs) results in the acquisition of mesenchymal traits and in the expression of stem-cell
markers [174]. Furthermore, they showed that these cells have an increased ability to form
mammospheres, a property associated with mammary epithelial stem cells. Also, stem cell-like
cells isolated from HMLE cultures form mammospheres and express markers similar to those of
HMLEs that have undergone an EMT. Further they showed that stem-like cells isolated either
from mouse or human mammary glands or mammary carcinomas express EMT markers and
transformed human mammary epithelial cells that have undergone an EMT form
mammospheres, soft agar colonies, and tumors more efficiently. These findings illustrate a direct
link between the EMT and the gain of epithelial stem cell properties [174].
Presently only a very few studies have shown the importance of environmental
carcinogens in process of EMT [186-188] and generation of cancer stem cells [189] , therefore
more studies are needed to address this question. In the past decade the importance of cancer
stem cells in cancer severity and recurrence after chemotherapy has been a highly investigated
area. The increasing need to identify and target the cancer stem cell is a fast growing research
area; therefore it is important to identify the origin and role of cancer stem cell during the
precancerous stages of cancer progression. This will help to target and/or prevent the formation
of cancer stem cell in the beginning and might be a powerful tool in reducing the risk of cancer
relapse in patients.
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Using the chronic precancerous model we want to study the stem-like cell and EMT
related properties and markers induced by chronic exposure to environmental carcinogenesis that
lead to the transition of normal cells to pre malignant to malignant cells.

34

Dietary Cancer Prevention
Wide geographical variation in cancer incidence and mortality rates is thought to be due
to difference in lifestyle and environmental factors, including diet [190, 191]. Migrant studies
comparing individuals who move from countries with low rates to those with high rates, and
dynamic studies that link changes within countries to environmental or dietary change in those
countries have suggested that diet and other lifestyle factors substantially influence cancer risk
[192, 193]. Doll and Peto [109] suggested that dietary factors might contribute to an estimated
one-third of all cancer deaths; however, this estimate can vary from 10% to 70% [194].
According to WHO at least 30–40% of all cancer deaths are preventable [195]. This means, that
of the 7.4 million cancer deaths (or 13% of the total number of deaths worldwide) in 2004, 2.2–
2.9 million could have been prevented [196]. More than 200 studies have examined the
relationship between fruit and vegetable intake and cancers of the various organs, including,
lung, colon, breast, cervix, esophagus, oral cavity, stomach, bladder and pancreas [197].
Natural dietary agents including fruits, vegetables, and spices have drawn a great deal of
attention from both the scientific community and the general public owing to their ability to
suppress cancers [198]. The questions that remain to be answered are which component of these
dietary agents is responsible for the anti-cancer effects and what is the mechanism by which they
suppress cancer. Fruits and vegetables are excellent sources of fiber, vitamins, and minerals, but
they also contain components like flavonoids, polyphenols, terpenes, alkaloids, and phenolics
that may provide substantial health benefits beyond basic nutrition. Research over the last decade
has shown that several micronutrients in fruits and vegetables reduce cancer [198]. Given the
important role of diet in cancer prevention, a better understanding of the preventive approaches
needs to be taken seriously. Early detection, treatment and prevention would seem to constitute
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the complete strategy for cancer control (Figure 1.12). Effective anticancer strategies are
therefore crucial and should meet specific criteria in order to succeed. These strategies must be
practical and focus on high-risk populations, such as smoker [196].
Cancer preventive substances in vegetables and fruit
Many potentially anti-carcinogenic substances have been identified in vegetables and
fruit, some of these substances are listed in Table 1.2. Some of these compounds are
characteristic of particular classes of vegetables and fruit [199]. For example, cruciferous
vegetables are unique in their high content of dithiolthiones and isothiocyanates; these are
organosulfur compounds that have been shown to increase the activity of enzymes involved in
the detoxification of carcinogens and other foreign compounds [200]. The allium vegetable
family includes onions, garlic, scallions, leeks, and chives and is notable for its content of
compounds such as diallyl sulfide and allyl methyl trisulfide, which have been shown to induce
enzymatic detoxification systems [201]. Soybeans contains isoflavones like, genistein which has
been shown to inhibit the activity of tyrosine kinase, an enzyme involved in the transmission of
signals from cellular growth factor receptors that is expressed at high levels in transformed cells
[202]. Citrus fruit is known for its high content of vitamin C, which, as an antioxidant, may
protect cell membranes and DNA from oxidative damage. Vitamin C may further help prevent
cancer via its ability to scavenge and reduce nitrite, thereby reducing substrate for the formation
of nitrosamines [203]. Green leafy vegetables contain lutein, a carotenoid and xanthophyll
pigment which is an antioxidant and may protect against cancer via its ability to block damage
by free radicals [204]. Orange vegetables, such as carrots, sweet potatoes, winter squash, and
pumpkin, are relatively rich sources of beta carotene, as are some fruits, including papaya,
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mango, and cantaloupe. Beta carotene, like other carotenoids, is an antioxidant; through this
function it may protect against free radical damage [205].
Many other potentially anticarcinogenic substances are not limited to one type of
vegetable or fruit but are more widespread. Flavonoids, such as quercetin and kaempferol, are
polyphenolic antioxidants that occur in vegetables and fruit (tea and wine are also important
sources) [206]. In addition to being antioxidants, flavonoids may defend cells against
carcinogens via their ability to increase the pump-mediated efflux of certain carcinogens from
cells [207] or via induction of detoxification enzymes [208]. Fruit, vegetables, and legumes are
major sources of dietary fiber, which has been widely hypothesized to be protective against
colon cancer [209].
Therefore, various types of vegetables and fruits have different active compounds that
can help prevent cancer through multiple mechanisms, so a balanced healthy diet is
recommended for cancer prevention [199]. In this study we have examined the importance of
two dietary compounds, green tea and grape seed, in prevention of chronic breast cancer
carcinogenesis.

Green Tea
Green tea is made solely with the leaves of Camellia sinensis that have undergone
minimal oxidation during processing. It is the most globally consumed beverage in the world.
[210, 211]. It is estimated that about 2.5 million tons of tea leaves are produced throughout the
world each year with 20% produced as green tea, which is mainly consumed in Asia, some parts
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of North Africa, the United States, and Europe [211]. It contains characteristic polyphenolic
compounds, (-)-epigallocatechin-3-gallate (EGCG), (-)-epigallocatechin (EGC), (-)-epicatechin3-gallate (ECG), and (-)-epicatechin (EC), the usual composition is 10–15% EGCG, 6–10%
EGC, 2–3% ECG, and 2% EC [212].
A growing body of evidence from laboratory animal studies demonstrates that tea
consumption has an inhibitory effect on carcinogenesis at various organ sites. For example, oral
administration of tea infusion can inhibit the development of experimental rodent skin
tumors,[213] growth of implanted tumor cells,[214] invasion and metastasis of malignant
tumors, [215, 216] and angiogenesis [217, 218]. At present, epidemiological studies have not
yielded conclusive evidence of the protective effect of tea consumption against the development
of human cancers [219-221]. However, limited epidemiological studies suggest that people
drinking more cups of tea regularly have a lower risk of prostate and breast cancer [222-224].
Animal studies show that green tea catechin extract (GTC) is able to suppress rat
mammary

carcinogenesis

induced

by

7,12-dimethylbenz[a]anthracene

and

N-methyl-

Nnitrosourea [225, 226]. Laboratory studies also have shown that GTC possesses inhibitory and
apoptotic activity in human breast cancer cells in cultures [227, 228]. Although controversial,
epidemiological studies have examined the benefits of tea consumption for breast cancer
prevention, and some evidence has indicated that green tea consumption may help prevent breast
cancer recurrence in early stage cancers [229-231]. Thus, it is important to identify carcinogens
whose induction of breast cell carcinogenesis can be intervened by green tea components to
reveal targets for dietary prevention.
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Epicatechin (EC)
Catechin possesses two benzene rings (called the A- and B-rings) and a dihydropyran
heterocycle (the C-ring) with a hydroxyl group on carbon 3. Two of the isomers are in transconfiguration and are called catechin and the other two are in cis configuration and are called
epicatechin (Figure 1.13a). Epicatechin is a flavanol commonly present in higher plants, its
present in high content in certain food plants, such as Vitis vinifera (grape wine), Camellia
sinensis (tea), and Theobroma cacao (cocoa). Mice studies have identified that when animal is
given a single modest dose of epicatechin and then followed by induction of ischemic stroke by
cutting off blood supply to the animals' brains they suffered significantly less brain damage than
animals that had not been given the compound [232]. Epicatechin and its dimers have been
shown to inhibit NADPH-oxidase and the subsequent superoxide production [233]. Also,
epicatechin could act at different levels in signaling pathways involving protein kinases and
phosphatases and some studies show its role in preventing gastrointestinal cancer [233].
Epicatechin-3-gallate (ECG)
Epicatechin gallate is a flavan-3-ol, a type of flavonoid, present in green tea (Figure
1.13b). ECG can interfere with multiple cell signaling pathways and has multiple targets within
the cells, which are likely to interact together to reduce the risk of carcinogenesis. These
mechanisms include (a) inhibition of phase 1 CYP enzymes, (b) induction of phase II
detoxification and antioxidant enzymes, (c) anti-inflammatory efficacy (d) arrest of cell cycle
progression, (e) regulation of pro-apoptotic properties and (f) mediation of metastasis processes
[234-238]. Many of the anti-carcinogenic affects of ECG may be due to its direct and/or indirect
interaction with numerous molecular targets [239] such as NAG-1, AP-1, 5α-reductase and
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PDGF. Importantly, these growth inhibitions of ECG have been shown to sensitize cancer cells,
but not in normal cells. ECG may also inhibit RNase A and MMPs enzymatic activity via
chelating copper and zinc metals, which are important cofactors for angiogenesis and metastasis.
Furthermore, structure function analysis revealed that the gallate moiety of ECG is important for
mediating these inhibitory effects which these acts may enhance chemoprevention ability [238].
Epigallocatechin (EGC)
Epigallocatechin is a flavan-3-ol, a type of chemical compound including catechin, with
the gallate residue being in an isomeric cis position (Figure 1.13c). The major sources of EGC
are green tea, along with bananas, persimmon and pomegranate. ECG has shown to potentiate
effect on high K+-induced contraction in isolated porcine coronary arteries without endothelium
[240], suppressed growth of human melanoma cell line UACC-375 [241]. More studies are
needed to identify the role of EGC in other type of cancer prevention.
Epigallocatechin-3-gallate (EGCG)
Epigallocatechin 3-gallate (EGCG), is the ester of epigallocatechin and gallic acid
(Figure 1.13d). EGCG is the major component of the polyphenolic fraction of green tea. Along
with other tea catechins, and polyphenols in general, it is an antioxidant that is thought to prevent
tumorigenesis by protecting cellular components from oxidative damage via free radical
scavenging. Increasing number of evidences indicate that EGCG can be beneficial in treating
brain, prostate, cervical and bladder cancers [242-244]. EGCG has been shown to bind and
inhibit the anti-apoptotic protein Bcl-xl [245], which has been implicated in both cancer cell and
normal cell survival [246]. Indeed, a number of studies have demonstrated the free radical
scavenging activites of EGCG, as well as its antimutagenic, antitumorigenic, anti-angiogenic,
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antiproliferative, and/or pro-apoptotic effects on mammalian cells both in vitro and in vivo. Also,
wide variety of research shows EGCG restrained carcinogenesis in a variety of tissues through
inhibition of mitogen-activated protein kinases (MAPK), growth factor-related cell signaling,
activation of activator protein 1 (AP-1) and nuclear factor-B (NF-kappaB), topoisomerase I,
matrix metalloproteinases and other potential targets. Therefore, EGCG is a multipotent
anticancer agent, which not only provides solid evidence to support the anticancer potential of
green tea, but also offers new clues for discovering multiple-targeted anticancer drug [247].

Grape Seed
Grape seed extracts are industrial derivatives from whole grape (Vitis vinifera) seeds that
have a great concentration of vitamin E, flavonoids, linoleic acid and polyphenols, including
oligomeric proanthocyanidins which are recognized as antioxidants. Within the superfamily of
polyphenolic compounds are proanthocyanidins, which are enriched in grape seeds and are
oligomers and polymers (Figure 1.14) of the catechin family [248]. Grape seed
proanthocyanidin extract (GSPE) has been shown to exhibit antioxidant and anticancer activities
in both in vitro and in vivo models [249-252]; for example, it shows some diet-dependent,
chemopreventive activity in a rat model with mammary cancer induced by 7,12dimethylbenz[a]anthracene (DMBA) [252]. GSPEs have been shown to be potent antioxidants
and free radical scavengers, being more effective than either ascorbic acid or vitamin E [253,
254]. Furthermore, GSPEs have been shown to have anticarcinogenic activity in different cancer
like, skin, colorectal, prostate and breast cancers [255]. Thus scientific research shows
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consumption of grapes and/or grape-related products in diets along with maintaining an active
healthy lifestyle has both practical and translation potential in the fight against cancer and is thus
beneficial to the general population [255]. Whether dietary GSPE is able to prevent the breast
cell carcinogenesis associated with chronic exposures to environmental carcinogens needs to be
studied.
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Table 1.1
List of known EMT markers
Proteins that increase in abundance

Proteins whose activity increases

N-cadherin

ILK

Vimentin

GSK-3β

Fibronectin

Rho

Snail1 (Snail)

Proteins that accumulate in the nucleus

Snail2 (Slug)

β-catenin

Twist

Smad-2/3

Goosecoid

NF-κβ

FOXC2

Snail1 (Snail)

Sox10

Snail2 (Slug)

MMP-2

Twist

MMP-3

In vitro functional markers

MMP-9

Increased migration

Integrin αvβ6

Increased invasion

Proteins that decrease in abundance

Increased scattering

E-cadherin

Elongation of cell shape

Desmoplakin

Resistance to anoikis

Cytokeratin

Modified from Journal of Cell Biology 2006 Mar 27;172(7):973-81.
The epithelial-mesenchymal transition: new insights in signaling, development, and disease.
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Table 1.2
List of cancer preventive substances and their common sources
Preventive Compound

Source

Allium Compound

Onions, garlic, scallions, leeks, and chives

Carotenoids

Carrots, sweet potatoes, spinach, kale, collard greens, and
tomatoes, all dark green leafy vegetables

Coumarins

Tonka bean, mullein, cassia, cinnamon, sweet clover

Dietary fiber

Soybeans and other legumes

Flavonoids

Green tea, wine, citrus fruits, dark chocolate

Folic acid

Leafy vegetables, cereals

Indole-3-carbinal

Broccoli, cabbage, cauliflower, brussels sprouts, collard
greens and kale.

Isoflavones

Soybean, green bean, alfalfa sprout, cowpea

Isothiocyanate

Horseradish, mustard, radish, brussels sprouts, watercress,
nasturtiums and capers.

Vitamin C

Citrus fruits, chilies, broccoli, strawberries
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Modified from Susan G. Komen website (http://www.komennyc.org)

Figure 1.1
Worldwide Breast cancer incidence in 2007
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Modified from American Society for Clinical Oncology (http://www.asco.org/)

Figure 1.2
Stages of Breast Cancer as described by American Cancer Institute
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Modified from Breast Cancer Organization (http://www.breastcancer.org/)

Figure 1.3
Risk factors for breast cancer
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Adapted from Cancer News in Context (http://www.cancernewsincontext.org/)

Figure 1.4
Environmental or non-hereditary potential cancer-causers
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(A)

Adapted from Wikipedia
(B)

Adapted from Wikipedia

Figure 1.5
Chemical structure of carcinogens
(A) Chemical structure of 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone
(B) Chemical structure of benzo[a]pyrene
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Modified from Nature Reviews Cancer. 2003 Jan;3(1):11-22.
Targeting RAS signalling pathways in cancer therapy.

Figure 1.6:
Ras activation and ERK pathway
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Adapted from Trends Cellular Biology 2005 Sep;15(9):494-501.
Cancer stem cells: lessons from leukemia.

Figure 1.7
Models of Cancer Progression
(A) Stochastic Model
(B) Stem cell Model
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Adapted from Nature. 2001 Nov 1;414(6859):105-11.
Stem cells, cancer, and cancer stem cells.

Figure 1.8
Origin of cancer stem cells
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Adapted from Nature Review Cancer. 2003 Nov;3(11):832-44.
Stem cells and breast cancer: A field in transit.

Figure 1.9
Dynamicity of mammary gland
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Modified from Journal of Clinical Investigation 2009 Jun;119(6):1420-8.
The basics of epithelial-mesenchymal transition.

Figure 1.10
Changes during Epithelial to Mesenchymal
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Modified from Journal of Cell Biology 2006 Mar 27;172(7):973-81.
The epithelial-mesenchymal transition: new insights in signaling, development, and disease.

Figure 1.11
Pathways activated during Epithelial to Mesenchymal Transition
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Adapted from Nature Reviews Cancer Jul;9(7):508-16
Cancer prevention research - then and now.

Figure 1.12
Complete strategy for eliminating cancer.

87

Adapted from Journal of Nutrition Jun;129(6):1094-101.
Jasmine green tea epicatechins are hypolipidemic in hamsters fed a high fat diet.

Figure 1.13
Chemical structure of Catechins
(A) Chemical structure of Epicatechin
(B) Chemical structure of Epicatechin-3-gallate
(C) Chemical structure of Epigallocatechin
(D) Chemical structure of Epigallocatechin-3-gallate
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Adapted from Wikipedia

Figure 1.14
Chemical structure of Proanthocyanidin
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PART –II

Green tea catechin extract in intervention of chronic breast
cell carcinogenesis induced by environmental carcinogens

90

Research described in this chapter is slightly modified version of an article that is published in
2011 in Molecular Carcinogenesis by Kusum Rathore and Hwa-Chain Robert Wang

Kusum Rathore and Hwa-Chain Robert Wang. Green tea catechin extract in intervention of
chronic breast cell carcinogenesis induced by environmental carcinogens.
Molecular Carcinogenesis. 2011 Aug 31. doi: 10.1002/mc.20844.
Copyright © 2011 Wiley-Liss, Inc.

In this paper “our” and “we” refers to me and co-authors. My contribution in the paper includes
(1) Selection of the topic (2) Compiling and interpretation of the literature (3) Designing
experiments (4) understanding the literature and interpretation of the results (5) providing
comprehensive structure to the paper (6) Preparation of the graphs and figures (7) Writing and
editing
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Abstract

Sporadic breast cancers are mainly attributable to long-term exposure to environmental
factors, via a multi-year, multi-step, and multi-path process of tumorigenesis involving
cumulative genetic and epigenetic alterations in the chronic carcinogenesis of breast cells from a
non-cancerous stage to precancerous and cancerous stages. Epidemiologic and experimental
studies have suggested that green tea components may be used as preventive agents for breast
cancer control. In our research, we have developed a cellular model that mimics breast cell
carcinogenesis chronically induced by cumulative exposures to low doses of environmental
carcinogens. In this study, we used our chronic carcinogenesis model as a target system to
investigate the activity of green tea catechin extract (GTC) at non-cytotoxic levels in intervention
of

cellular

carcinogenesis

induced

by

(methylnitrosamino)-1-(3-pyridyl)-1-butanone

cumulative
(NNK)

and

exposures

to

benzo[a]pyrene

pico-molar

4-

(B[a]P).

We

identified that GTC, at a non-cytotoxic, physiologically-achievable concentration of 2.5 g/mL,
was effective in suppressing NNK- and B[a]P-induced cellular carcinogenesis, as measured by
reduction of the acquired cancer-associated properties of reduced dependence on growth factors,
anchorage-independent growth, increased cell mobility, and acinar-conformational disruption.
We also detected that intervention of carcinogen-induced elevation of reactive oxygen species
(ROS), increase of cell proliferation, activation of the ERK pathway, DNA damage, and changes
in gene expression may account for the mechanisms of GTC's preventive activity. Thus, GTC
may be used in dietary and chemoprevention of breast cell carcinogenesis associated with longterm exposure to low doses of environmental carcinogens.
92

Introduction
More than 70% of sporadic breast cancers are attributable to long-term exposure to
environmental factors, such as chemical carcinogens; this chronic disease process involves
accumulated genetic and epigenetic alterations to induce progressive carcinogenesis of breast
cells from non-cancerous to precancerous and cancerous stages [1-4]. The current paradigm of
experimental studies routinely uses high doses of carcinogens (micro- to milli-molar
concentrations) to induce cancerous cells in cultures and tumors in animals as steps in evaluating
the potency of carcinogens [1,3,5]. However, considering that long-term, chronic exposure to
low doses of carcinogens is responsible for human breast cancer, a high-dose approach may not
be a proper way to study environmental carcinogens in human breast cancer development.
We have been developing a cellular model to mimic chronic breast cell carcinogenesis
occurring with accumulated exposures to low doses of environmental carcinogens, such as 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and/or benzo[a]pyrene (B[a]P) [6-9].
NNK is a tobacco-specific carcinogen [10,11]. Although gastric administration of NNK into rats
results in DNA-adduct formation in the mammary gland [12] and development of mammary
tumors [13], NNK is not currently recognized as a mammary carcinogen. B[a]P is an
environmental, dietary, and tobacco carcinogen [14-18]. Epidemiologic, animal, and cellular
studies indicate that B[a]P may contribute to sporadic breast cancer development through its
metabolites forming DNA-adducts causing DNA lesions [17-20]. However, the association
between smoking and breast cancer is still controversial; some studies have indicated there is no
influence of smoking on breast cancer incidence [21], and some studies have shown a correlation
between them [22]. Recently, a study was conducted by four major Canadian agencies to address
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this controversy, and the results indicate that active smoking and second-hand smoke increase
breast cancer risk [23]. Another recent cohort study in the United States has also shown a
connection between smoking and breast cancer in post-menopausal women [24]. Thus, the role
of smoking in increasing the incidence of breast cancer should be taken seriously. Our model
system has successfully revealed that NNK and B[a]P, at pico-molar ranges, like those detected
in patients, are able to induce non-cancerous breast epithelial MCF10A cells to increasingly
acquire cancer-associated properties via cumulative exposures [6-9].
The use of green tea to increase the body‟s antioxidant activity is becoming increasingly
popular in the Western world [25]. Animal studies show that green tea catechin extract (GTC) is
able to suppress rat mammary carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and
N-methyl-N-nitrosourea [26,27]. Laboratory studies also have shown that GTC possesses
inhibitory and apoptotic activity in human breast cancer cells in cultures [28,29]. Although the
are controversial, epidemiological studies have examined the benefits of tea consumption for
breast cancer prevention, and some evidence has indicated that green tea consumption may help
prevent breast cancer recurrence in early stage cancers [30-32]. Thus, it is important to identify
carcinogens whose induction of breast cell carcinogenesis can be intervened by green tea
components to reveal targets for dietary prevention. Using our cellular model as a target, we
have tested the ability of GTC at a non-cytotoxic concentration of 40 g/mL to suppress, by
more than 50%, the acquisition of cancer-associated properties induced by cumulative exposures
to 100 pmol/L of B[a]P [7]. Hence, it is important to pursue an extended study to reveal the
effectiveness and mechanisms of GTC in intervention of chronic breast cell carcinogenesis
caused by NNK and B[a]P for developing targeted intervention of breast cell carcinogenesis.
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In this study, we used our cellular model as a target and investigated the minimal
concentration of GTC required for intervention of NNK- and B[a]P-induced cellular
carcinogenesis. We also investigated the mechanisms for GTC in counteracting the activity of
NNK and B[a]P in inducing cellular, biochemical, and molecular changes on initiation of cellular
carcinogenesis.

Materials and Methods
Cell Cultures and Reagents

MCF10A (American Type Culture Collection [ATCC], Rockville, MD) and derived cells
were maintained in complete (CM) medium (1:1 mixture of DMEM and Ham‟s F12,
supplemented with mitogenic additives including 100 ng/ml cholera enterotoxin, 10 g/ml
insulin, 0.5 g/ml hydrocortisol, 20 ng/ml epidermal growth factor, and 5% horse serum) and
supplemented with 100 units/ml penicillin and 100 g/ml streptomycin [6-9]. All the cultures
were maintained in 5% CO2 at 37°C. Stock aqueous solutions of NNK (Chemsyn, Lenexa, KS),
B[a]P (Aldrich, Milwaukee, WI), and chloromethyl-dichlorodihydro-fluorescein-diacetate (CMH2DCF-DA) (Invitrogen, Carlsbad, CA) were prepared in DMSO and diluted with culture
medium for assays. GTC (Polyphenon-60, a mixture of polyphenolic compounds containing 60%
total catechins, Sigma, St. Louis, MO) was prepared in distilled water and diluted with medium.
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Induction and Suppression of Cell Carcinogenesis
Twenty-four hours after each subculturing, MCF10A cells were treated with combined
NNK and B[a]P each at 100 pmol/L in the absence and presence of GTC for 48 h as one cycle of
exposure for 10 cycles; cultures were subcultured every 3 d.

Cell Viability Assay
A Methyl Thiazolyl Tetrazolium (MTT) assay kit (ATCC) was used to measure cell growth
and viability in cultures. Five x 103 cells were seeded into each well of 96-well culture plates.
After treatments, cultures were incubated with MTT reagent for 4 h, followed by incubation with
detergent reagent for 24 h. Reduced MTT reagent in cultures was quantified with an ELISA
reader (Bio-Tek, Winooski, VT).

Cell Proliferation Assay
Five x 103 cells were seeded into each well of 96-well culture plates. After treatments,
using the 5-bromo-2-deoxyuridine (BrdU) cell proliferation ELISA kit (Roche, Indianapolis, IN),
cultures were labeled with BrdU for 12 h, fixed, incubated with peroxidase-conjugated BrdUspecific antibodies, and stained with the peroxidase substrate. Quantification of BrdU-labeled
cells was determined with an ELISA reader (Bio-Tek).
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Apoptosis Assay
An annexin-V-fluorescein isothiocyanate (FITC) apoptosis detection kit with propidium
iodide (BD Biosciences, San Jose, CA) was used to detect apoptotic cell death by flow
cytometry, as described previously [33]. Flow cytometric analysis was performed on the Coulter
EPICS Elite Cytometer (Hialeah, FL) at the excitation and emission wavelengths of 488 and 550
nm, respectively, for FITC measurements, and at 488 and 645 nm for propidium iodide
measurements. Percentage of cells undergoing apoptosis was determined using Multicycle
software (Phoenix Flow System, San Diego, CA).

Reduced Dependence on Growth Factors Assay
The low-mitogen (LM) medium contained total serum and mitogenic additives reduced to
2% of the concentration formulated in CM medium as described above [7-9]. Three × 103 cells
were seeded in LM medium; growing colonies that reached 0.5 mm diameter in 10 d were
counted.

Anchorage-independent Cell Growth Assay
The base layer consisted of 2% low-melting agarose (Sigma) in CM medium. Then, soft
agar consisting of 0.4% low-melting agarose in a mixture (1:1) of CM medium with 3-d
conditioned medium prepared from MCF10A cultures was mixed with 5 × 103 cells and plated
on top of the base layer in 60-mm diameter culture dishes [7-9]; growing colonies that reached
0.1 mm diameter in 20 d were counted.
97

Acinar-Conformational Disruption Assay
Placed as a Matrigel base of reconstituted basement membrane in each well of 24-well
culture plates was 400 mL of growth factor-reduced Matrigel Matrix (BD Biosciences) [7, 8, 34].
Two × 103 cells were mixed with CM medium containing 4% Matrigel and plated on top of the
base layer of Matrigel. Cultures were maintained in 5% CO2 at37°C and were replaced with fresh
CM medium containing 2% Matrigel every 3 d for 14 d. Spheroids in Matrigel were collected
and overlaid with 5% agarose; then blocks of agarose-packed Matrigel spheroids were fixed in
neutral-buffered formalin and embedded in paraffin for histological examination of 5-mm H&Estained sections.

Cell Motility Assay
Cells were grown to confluence in CM medium, rinsed with PBS, and maintained in
DMEM/Ham‟s F12 media supplemented with 2% serum for 15 h [35]. The monolayer was
scratched with a 23-gauge needle (BD Biosciences) to generate wounded areas and rinsed with
CM medium to remove floating cells. Cultures were maintained in CM medium, and the
wounded areas were examined 6 h and 24 h after scratches. Wound healing area was calculated
by using Total Lab TL100 software (Total Lab, Newcastle, NE).
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Intracellular ROS Measurement
Cultures were labeled with 5 μmol/L CM-H2DCF-DA for 1 h [36]. Cells were trypsinized
from cultures and resuspended in PBS for analysis of ROS by flow cytometry, using a 15 mW,
air-cooled argon laser to produce 488 nm light. DCF fluorescence emission was collected with a
529 nm band pass filter. The mean fluorescence intensity of 2 × 104 cells was quantified using
Multicycle software (Phoenix Flow System).

Western Immunoblotting
Cell lysates were prepared in buffer (10 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100,
5 mM EDTA, 10 mM sodium pyrophosphate, 10% glycerol, 0.1% Na3VO4, 50 mM NaF, pH 7.4)
[8,9]. Protein concentration in cell lysates was measured using the BCA assay (Pierce, Rockford,
IL). Equal amounts of cellular proteins were resolved by electrophoresis in 10 or 12% SDSpolyacrylamide gels for Western immunoblotting with antibodies specific to phosphorylated
Mek1/2 (p-Mek1/2), Mek1/2, p-Erk1/2, p-H2AX, H2AX (Cell Signaling, Beverly, MA), Erk1/2,
and β-Actin (Santa Cruz, Santa Cruz, CA). Antigen-antibody complexes on filters were detected
by the Supersignal chemiluminescence kit (Pierce).

Gene Expression Study with Microarrays
MCF10A cells were treated with combined NNK and B[a]P each at 100 pmol/L in the
absence or presence of 40 µg/mL of GTC for 24 h. Total RNA was isolated from cultures using
the Absolutely RNA kit (Stratagene, La Jolla, CA). RNA quality and integrity were determined
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using an Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA). High-quality RNA, with an RNA
Integrity Number of >7.0 and an A260/280 absorbance ratio of >1.8, was used for studies.
Detection of gene expression was completed through a purchased service using the Human
OneArray, which contains 29,187 human genome probes and 1088 experimental control probes
formed as 60-mer sense-strand DNA elements (PhalanxBio, Palo Alto, CA). All experiments
were performed in duplicate; RNA was prepared from two independent cultures for each
experiment. The data was analyzed using Array Studio Online (OmicSoft, Morrisville, NC). The
relative gene expression levels in carcinogen- and GTC-treated cultures were normalized with
levels in their counterpart, parental MCF10A cells and then were reciprocally compared to detect
differentially expressed genes in GTC- and carcinogen (only)-treated cultures versus carcinogentreated cultures.

Reverse Transcription PCR
One µg of total RNA isolated from cultures using the Absolutely RNA kit (Stratagene)
was reverse transcribed to cDNA using a Versoc DNA Kit (Thermo Scientific, Waltham, MA).
The

resulting

cDNAs

were

TCTAATTGAGGCCCACAAGG-3‟;
TNFRSF8

(forward:

subjected
reverse:

to

PCR

for

COX17

(forward:

5‟-

5‟-ATTCACACAGCAGACCACCA-3‟),

5‟-AAACCGCTCAGATGTTTTGG-3‟;

reverse:

5‟-

TGATGCAGAGACACCCACTC-3‟), S100P (forward: 5‟-TCCTGCAGAGTGGAAAAGAC3‟;

reverse:

5‟-TAGGGGAATAATTGCCAACA-3‟),

ATM

(forward:

5‟-

ACTGCCAAGGACAAATGAGG-3‟; reverse: 5‟-TGAGCAACTGAGTGGCAAAC-3‟), and βActin

(forward:

5‟-GGACTTCGAGCAAGAGATGG-3‟;
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reverse:

5‟-

AGCACTGTGTTGGCGTACAG-3‟). PCR was carried out as follows: 1 cycle at 95°C for 2
min, 45 cycles at 95°C for 30 s and 58°C for 45 s, and the final extension of 1 cycle at 72°C for
30 s. PCR products were electrophoresed on 2% agarose gel and visualized after ethidium
bromide staining.

Statistical Analysis
To statistically verify the suppression of NNK- and B[a]P-induced carcinogenesis by
GTC, one-way analysis of variance (ANOVA) test was used to establish significant difference
among the various treatment groups at P < 0.01, followed by Duncan‟s Multiple Range Test.
Statistical significance of all the other studies was analyzed by Student t test (P ≤ 0.05) and α
levels were adjusted by the Simes method [37].

Results and Discussion

Determination of GTC Cytotoxicity
Considering the side-effects resulting from long-term use of anticancer agents in
intervention of cellular carcinogenesis, use of non-cytotoxic levels of dietary components has to
be adopted into strategies for cancer prevention. To determine the cytotoxicity of GTC to noncancerous breast epithelial cells, we investigated the biological effects of GTC at various
concentrations on viability, proliferation, and cell death of MCF10A cells. We detected cytotoxic
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activity of GTC at 100 µg/mL, but not at 0.5, 2.5, 10, and 40 µg/mL, in reducing cell viability
(Figure 2.1A), inhibiting cell proliferation (2.1B), or inducing apoptotic cell death (2.1C).
Accordingly, GTC at 0.5, 2.5, 10, and 40 µg/mL was non-cytotoxic to MCF10A cells.

GTC Suppression of NNK- and B[a]P-induced Carcinogenesis
In our chronic carcinogenesis model, cumulative exposures of MCF10A cells to picomolar NNK and B[a]P result in progressive acquisition of various cancer-associated properties
[7-9]. Using cancer-associated properties as target endpoints, we investigated the activity of GTC
in suppression of NNK- and B[a]P-induced cellular carcinogenesis. A lack of growth factors
causes normal cells to become growth-arrested in the cell cycle and to commit apoptosis;
however, aberrantly-increased cell survivability acquired to reduce dependence on growth
factors can lead cells to tumorigenic transformation [38-40]. Cell adhesion to extracellular
matrixes is important for cell survival in a multi-cell environment; aberrantly-increased cell
survivability acquired to promote anchorage-independent growth can render cells into
tumorigenic transformation [41,42]. Cancerous cells acquire an increased mobility compared
with their normal counterpart cells [43]. MCF10A cells were exposed to NNK combined with
B[a]P in the presence of GTC at 0, 0.5, 2.5, 10, and 40 µg/mL for 10 cycles, resulting in NB,
NB/G-0.5, NB/G-2.5, NB/G-10, and NB/G-40 cell lines, respectively. We detected that GTC at
2.5, 10, and 40 µg/mL significantly suppressed NNK- and B[a]P-induced acquisition of the
cancer-associated property of reduced dependence on growth factors to approximately 20, 40,
and 75%, respectively (Figure 2.2A-1), as well as anchorage-independent growth to
approximately 20, 50, and 80%, respectively (2.2B-1). Not only the numbers but also sizes of
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cell colonies were suppressed by GTC (Figure 2.2A-2 and 2.2B-2). Using the scratch/wound
assay [35], we detected that NB cells acquired high mobility to heal the wounded area in 24 h; in
contrast, parental MCF10A cells did not heal the wounded area; and NB/G-0.5, NB/G-2.5,
NB/G-10, and NB/G-40 cells showed various abilities to heal the wounded areas (Figure 2.2C1). Thus, co-exposure to GTC significantly reduced NNK- and B[a]P-induced acquisition of the
cancer-associated property of increased cell mobility in a dose-dependent manner (Figure 2.2C2).
In addition, both acinar structures with a hollow lumen and apicobasally polarized cells
are important characteristics found in glandular epithelia in vivo; the disruption of an intact
glandular structure is a hallmark of epithelial cancer even at precancerous stages [44,45]. As
shown in our previous studies [7-9], parental MCF10A cells mainly formed regular, round
spheroids on Matrigel cultures, and NNK-and B[a]P-exposed cells formed both regular and
irregular spheroids. Counting the regular and irregular spheroids in these cultures verified the
ability of GTC at 2.5, 10, and 40 µg/mL to significantly suppress NNK- and B[a]P-induced
development of irregular spheroids to approximately 10, 45, and 65%, respectively (Figure
2.2D-1). Histological examination revealed a hollow lumen and apicobasal polarization in
regular spheroids of MCF10A cells and GTC-protected, carcinogen-exposed cells (NB/G-40) as
well as the loss of apicobasal polarity and filling of the luminal space in irregular spheroids of
NNK- and B[a]P-exposed cells (NB) and NB/G-40 cells on Matrigel (Figure 2.2D-2). These
results indicated that GTC was able to protect MCF10A cells from acquiring the cancerassociated property of acinar-conformational disruption induced by NNK and B[a]P in a dosedependent manner.

Analysis of all these results together indicated that GTC at 2.5, 10, and 40

µg/mL was effective to significantly suppress NNK- and B[a]P-induced cellular carcinogenesis
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quantitatively and qualitatively. Clinical and animal studies showed an achievable plasma level
of GTC at ≈4 µg/mL [46-49]. Therefore, GTC at 2.5 µg/mL can be bio-availably achieved for
dietary intervention and chemoprevention of breast cell carcinogenesis associated with long-term
exposure to environmental carcinogens.
MCF10A cells repeatedly treated with combined NNK and B[a]P each at 100 pmol/L for
10 cycles acquired various cancer-associated properties but did not acquire tumorigenicity to
develop any detectable xenograft tumors in immunodeficient nude mice (data not shown). It has
been shown that NNK is able to induce mammary tumors in rats [13], and it is recognized that
exposure to B[a]P contributes to sporadic breast cancer development [17-20]. Although NNK
and B[a]P are recognized as precancerous breast carcinogens in our model, whether additional
exposures to NNK and B[a]P may induce cellular tumorigenicity remains to be determined.
Thus, our model is able to detect precancerous carcinogenesis of breast cells and identify
preventive agents to intervene in precancerous breast cell carcinogenesis for early prevention of
breast cancer associated with long-term exposure to low doses of environmental and tobacco
carcinogens.

GTC Suppression of Carcinogen-induced ROS, Cell Proliferation, the ERK Pathway, and
H2AX Phosphorylation
Short-term exposure of MCF10A cells to the B[a]P metabolites B[a]P-quinones at 10
µmol/L induces ROS [50]. Short-term exposure of normal human bronchial epithelial cells to
NNK at 1-5 µmol/L induces cell proliferation [51]. It has been postulated that ROS elevation and
increased proliferation may promote cell susceptibility to DNA damage induced by carcinogens,
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contributing to cellular carcinogenesis [52,53]. However, it is not clear whether MCF10A cell
carcinogenesis induced by cumulative exposures to NNK and B[a]P at 100 pmol/L is contributed
by ROS elevation, proliferation, and DNA damage during each exposure. To address this
question and to pursue the mechanisms for GTC in counteracting the activity of NNK and B[a]P
in initiation of cellular carcinogenesis, we studied the activity of GTC in modulation of NNKand B[a]P-induced ROS elevation, cell proliferation, proliferation-associated signaling pathways,
and DNA damage. As shown in Figure 2.3, treatment with NNK and B[a]P for 24 h induced
ROS elevation (A), cell proliferation (B), activation of the ERK pathway (indexed by
phosphorylation of Mek1/2 and Erk1/2) [54] (C), and DNA damage (indexed by phosphorylation
of H2AX on serine-139) [55] (C). Co-treatment with GTC at 2.5, 10, and 40 µg/mL resulted in a
dose-dependent reduction of these carcinogen-induced biological and biochemical outcomes.
Accordingly, suppression of carcinogen-induced ROS elevation, cell proliferation, ERK
activation, and DNA damage may account for the mechanism of GTC in intervention of cellular
carcinogenesis. However, the targets involved in ROS elevation, cell proliferation, ERK
activation, and DNA damage for GTC suppression of NNK- and B[a]P-initiated carcinogenesis
are to be identified.

GTC Intervention of Carcinogen-induced Gene Expression
To further our investigation of GTC activity in intervention of NNK- and B[a]P-initiated
carcinogenesis, we used cDNA microarrays to detect differentially regulated genes that were
changed in carcinogen-treated cells but whose changes were suppressed by GTC. Initially, we
identified genes whose expressions were changed in carcinogen-treated cells compared to their
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counterpart expression levels in untreated cells. After normalization, more than 11,000 genes
were detectably expressed in these cells. Filtering with the t test (P < 0.05) revealed 479
differentially expressed genes in carcinogen-treated cells, more than 2-fold over counterpart
expression in untreated, counterpart cells. Subsequently, we identified genes whose expressions
were associated with ROS elevation, cell proliferation, the ERK pathway activation, and DNA
damage, but were not induced in GTC- and carcinogen-treated cells. As listed in Table 2.1, we
detected that three genes (BAX, COX17, and MRPL41) associated with ROS elevation, four
genes (B4GALT1, BARHL1, BOLA3, and MT1E) associated with cell proliferation, two genes
(S100P and SPRR1B) associated with ERK pathway activation, and two genes (ATM and PER1)
associated with DNA damage were up-regulated in carcinogen-treated cells but their upregulations were suppressed in GTC- and carcinogen-treated cells; in addition, one gene
(TNFRSF8) associated with negative regulation of cell proliferation was down-regulated in
carcinogen-treated cells but not down-regulated in GTC- and carcinogen-treated cells. To further
validate microarray results with an independent method, we arbitrarily chose a gene from each
category for reverse transcription PCR semi-quantification to measure relative gene expression
levels in cells treated with carcinogens and/or GTC. As shown in Figure 2.4, gene expression of
COX17, S100P and ATM, which were associated with ROS elevation, ERK pathway activation,
and DNA damage, respectively, were increased by NNK and B[a]P treatment; but NNK- and
B[a]P-increased expression of these genes was significantly reduced by co-treatment with GTC.
In contrast, TNFRSF8 gene expression associated with cell proliferation was reduced in cells
treated with NNK and B[a]P and up-regulated in cultures treated with GTC alone or GTC and
carcinogens. The PCR results were consistent with microarray data. Accordingly, expression of
these genes may be considered as a molecular target endpoint for GTC intervention of NNK- and
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B[a]P-initiated cellular carcinogenesis. However, their roles in carcinogen-induced ROS
elevation, cell proliferation, ERK activation, and DNA damage and GTC-induced suppression of
carcinogenesis are to be identified.
Our model presents unique features of chronic induction of breast cell carcinogenesis by
cumulative exposures to carcinogens, high sensitivity to detect low levels of carcinogens, and
measurable target endpoints. Applying this cellular model as a target will accelerate the
identification of dietary components for the formulation of combined supplements that can
effectively reduce the health risk of human cancers from long-term exposure to carcinogens
present in environmental pollution.
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Table 2.1
Table 2.1. Genes Up- and Down-regulated by NNK and B[a]P and Protected by GTC
Changes induced
Gene name

Function

by NNK & B[a]P

Expression associated with ROS elevation
BAX

Regulated by ROS via increasing

(BCL2-associated X protein)

promoter activity [56]

COX17

Regulate ROS elevation by

(Cytochrome c oxidase assembly

increasing activity of cytochrome c

homolog-17)

oxidase [57]

MRPL41

Induced by ROS to help stabilize p53

(Mitochondrial ribosomal

[58]

↑

↑

↑

protein L41)

Expression associated with cell proliferation
B4GALT1

Increase proliferation by enhancing

(BetaGlcNAc beta 1,4-

estrogen expression [59]

galactosyltransferase-1)
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↑

Table 2.1. Genes Up- and Down-regulated by NNK and B[a]P and Protected by GTC
Changes induced
Gene name

Function

by NNK & B[a]P

BOLA3

Increase proliferation by regulating

(BolA homolog-3)

cell cycle [61]

MT1E

Induce proliferation and migration of

(Metallothionein 1E)

bladder cancer cells [62]

TNFRSF8

Decrease proliferation and increase

(Tumor necrosis factor receptor

apoptosis [63]

↑

↑

↓

superfamily-8)

Expression associated with ERK pathway activation
S100P

Regulate Erk phosphorylation in

↑

(S100 calcium binding protein P) colon cancer cells [64]

SPRR1B

Regulated by ERK pathway in

(Small proline-rich protein 1B)

epithelial cells [65]
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↑

Table 2.1. Genes Up- and Down-regulated by NNK and B[a]P and Protected by GTC
Changes induced
Gene name

Function

by NNK & B[a]P

Expression associated with DNA damage

ATM

Induced by double strand DNA

(Ataxia telangiectasia mutated)

damage [55]

PER1

Induce DNA damage in human

(Period homolog-1)

cancer cells [66]

↑ up-regulation; ↓ down-regulation
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↑

Figure 2.1. Determination of GTC cytotoxicity. MCF10A cells were treated with 0, 0.5, 2.5,
10, 40, and 100 µg/mL of GTC for 48 h. (A) Quantification of cell viability was determined with
an MTT assay kit, and relative cell viability was normalized by the value determined in untreated
counterpart cells, set as 100%. (B) Cell proliferation was determined; relative cell growth rate
was normalized by the value of BrdU detected in untreated cells, set as 100%. (C) Apoptotic cell
population (%) was measured by flow cytometry with an Annexin-V-FITC Apoptosis Detection
Kit. Columns, mean of triplicates; bars, SD. The Student t test was used to compare the control
with each of the treatments to analyze statistical significance and P values adjusted for multiple
comparisons using the Simes method, indicated by
three independent experiments.
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**

P < 0.01. All results are representative of

Figure 2.1.
Determination of GTC cytotoxicity.
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Figure 2.2. GTC suppression of cellular carcinogenesis. MCF10A cells were exposed to NNK
combined with B[a]P each at 100 pmol/L in the presence of GTC at 0, 0.5, 2.5, 10, and 40µg/mL
for 10 cycles, resulting in NB, NB/G-0.5, NB/G-2.5, NB/G-10, and NB/G-40 cell lines,
respectively. (A-1 and A-2) To detect suppression effectivity of GTC on cellular acquisition of
reduced dependence on growth factors (RDGF), cells were then seeded and maintained in LM
medium for 10 d. Cell colonies (≥ 0.5 mm diameter) were stained and counted. (B-1 and B-2) To
detect suppression effectivity of GTC on cellular acquisition of anchorage-independent growth
(AIG), cells were seeded in soft-agar for 20 d. Colonies (≥ 0.1 mm diameter) were counted. The
percentage of suppression effectivity of GTC at various concentrations on NB-induced RDGF
(A-1) and AIG (B-1) were calculated by: {1 − [(# of NB/G-induced cell colonies) − (# of
MCF10A cell colonies)] ÷ [(# of NB-induced cell colonies) − (# of MCF10A cell colonies)]} x
100. Columns, mean of triplicates; bars, SD. The Student t test was used to compare the control
with each treatment to analyze statistical significance and P values adjusted for multiple
comparisons using the Simes method, indicated by * P < 0.05,

**

P < 0.01,

***

P < 0.001. (A-2

and B-2) colony numbers, average colony size, and range of colony size were determined in A-1
and B-1, respectively. Mean colony numbers in each treatment were analyzed by one-way
ANOVA at P < 0.01 to indicate significant difference in number of colonies in various
treatments. To further determine significant difference between individual treatments, a pairwise
analysis of variables was performed using the Duncan multiple range test. Significant differences
at P < 0.01 between treatments are labeled with different superscript letters (a, b, c, d, and e);
treatments labeled with the same superscript letters indicate no significant difference. (C-1 and
C-2) To detect suppression effectivity of GTC on cellular acquisition of increased cell mobility,
cells were seeded in CM medium and grown to confluence (a). A linear area of cell layer was
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removed from each culture with a 23-gauge needle to produce wounded cultures, and the
wounded areas were examined (×100 magnification) 6 h (b) and 24 h (c) after wounding. Arrows
indicate width of wounded areas. Results are representative of three independent experiments.
(C-2) To calculate the wound healing area, the area not healed by the cells was subtracted from
total area of initial wound to calculate the wound healing area at time intervals of 6 h (white
columns) and 24 h (hatched columns). (D-1 and D-2) To detect suppression effectivity of GTC
on cellular acquisition of acinar-conformation disruption (ACD), cells were seeded on Matrigel
for 12 d. Regular and irregular spheroids in each Matrigel culture were counted; and then the
percentage of irregular spheroids in each culture was calculated. The value of the suppression
effectivity of GTC on carcinogen-induced formation of irregular spheroids was calculated by:
{[(% of NB-induced irregular spheroid population) − (% of NB/G-induced irregular spheroid
population)] ÷ [(% of NB-induced irregular spheroid population) − (% of irregular spheroid
population in MCF10A cultures)]} x 100 (%). Columns, mean of triplicates; bars, SD. The
Student t test was used to compare the control with each treatment to analyze statistical
significance and P values were adjusted for multiple comparisons using the Simes method,
indicated by

*

P < 0.05,

**

P < 0.01,

***

P < 0.001. All results are representative of three

independent experiments. (D-2) Histological examination revealed acinar features of typical
regular spheroids of MCF10A, regular spheroids of NB/G-40, and irregular spheroids of NB and
NB/G-40 cells on Matrigel. Bars indicate50 µm.
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Figure 2.2.
GTC suppression of cellular carcinogenesis
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Figure 2.3. GTC suppression of carcinogen-induced ROS elevation, cell proliferation, the
ERK pathway, and phosphorylation of H2AX. MCF10A cells were treated with combined
NNK and B[a]P (NB) each at 100 pmol/L in the presence of 0, 0.5, 2.5, 10, and 40 µg/mL of
GTC for 24 h. (A) ROS levels were measured with CM-H2DCF-DA labeling; relative level of
ROS, as fold induction (X, arbitrary unit), was normalized by the level determined in untreated
counterpart cells, set as 1. (B) Cell proliferation was determined; relative cell growth rate was
normalized by the value of BrdU detected in untreated counterpart cells, set as 1. Columns, mean
of triplicates; bars, SD. The Student t test was used to compare the control with each treatment to
analyze statistical significance and P values adjusted for multiple comparisons using the Simes
method, indicated by * P < 0.05, ** P < 0.01, *** P < 0.001. (C) Cell lysates were prepared and
analyzed by Western immunoblotting to detect levels of phosphorylated Mek1/2 (p-Mek1/2),
Mek1/2, p-Erk1/2, Erk1/2, p-H2AX, H2AX, with β-Actin as a control. Levels of p-Mek1/2,
Mek1/2, p-Erk1/2, Erk1/2, p-H2AX, H2AX, and β-Actin were quantified by densitometry.
Levels of specific phosphorylation of Mek1/2 (p-Mek1/2/Mek1/2), Erk1/2 (p-Erk1/2/Erk1/2),
and H2AX (p-H2AX/H2AX) were calculated by normalizing levels of p-Mek1/2, p-Erk1/2, and
p-H2AX with levels of Mek1/2, Erk1/2, and H2AX, respectively, and then further normalizing
with β-Actin level and the level set in untreated cells (lane1) as 1 (X, arbitrary unit). All results
are representative of three independent experiments.
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Figure 2.3.
GTC suppression of carcinogen-induced ROS elevation, cell proliferation, the ERK
pathway, and phosphorylation of H2AX
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Figure 2.4. GTC intervention of carcinogen-induced gene expression. MCF10A cells were
treated with combined NNK and B[a]P (NB) each at 100 pmol/L in the presence of 40 µg/mL of
GTC for 24 h. Total RNAs were isolated and analyzed by reverse transcription PCR with
specific primers to determine relative gene expression levels of COX17, S100P, ATM, and
TNFRS8, with β-Actin as a control. Total gene expression levels of COX17, S100P, ATM,
TNFRS8, and β-Actin were quantified by densitometry. Relative gene expression levels were
calculated by normalizing the levels of COX17, S100P, ATM, and TNFRS8 gene expression
with β-Actin level and the level set in untreated cells (lane1) as 1 (X, arbitrary unit). All results
are representative of three independent experiments.
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Figure 2.4.
GTC intervention of carcinogen-induced gene expression

129

PART –III

Green tea catechin intervention of reactive oxygen speciesmediated erk pathway activation and chronically-induced
breast cell carcinogenesis
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Abstract
Long-term exposure to low doses of environmental carcinogens contributes to sporadic
human breast cancers. Epidemiologic and experimental studies indicate that green tea catechins
(GTCs) may intervene with breast cancer development. We have been developing a chronicallyinduced breast cell carcinogenesis model wherein we repeatedly expose non-cancerous, human
breast epithelial MCF10A cells to bio-achievable pico-molar concentrations of environmental
carcinogens,

such

as

4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

(NNK)

and

benzo[a]pyrene (B[a]P), to progressively induce cellular acquisition of cancer-associated
properties, as measurable endpoints. The model is then used as a target to identify non-cytotoxic
preventive agents effective in suppression of cellular carcinogenesis. Here, we demonstrate, for
the first time, a two-step strategy that initially used endpoints that were transiently-induced by
short-term exposure to NNK and B[a]P as targets to detect GTCs capable of blocking the
acquisition of cancer-associated properties, and subsequently used endpoints constantly-induced
by long-term exposure to carcinogens as targets to verify GTCs capable of suppressing
carcinogenesis. We detected that short-term exposure to NNK and B[a]P resulted in elevation of
reactive oxygen species (ROS), leading to Raf-independent ERK pathway activation and
subsequent induction of cell proliferation and DNA damage. These GTCs, at non-cytotoxic
levels, were able to suppress chronically-induced cellular carcinogenesis by blocking
carcinogen-induced, ROS elevation, ERK activation, cell proliferation, and DNA damage in each
exposure cycle. Our model may help accelerate the identification of preventive agents to
intervene in carcinogenesis induced by long-term exposure to environmental carcinogens,
thereby safely and effectively reducing the health risk of sporadic breast cancer.
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Introduction
More than 70% of sporadic breast cancers are attributable to long-term exposure to
environmental factors, such as chemical carcinogens, etc; this multi-year, multi-step, and multipath disease process involves cumulative genetic and epigenetic alterations to induce progressive
carcinogenesis of breast cells from non-cancerous to precancerous and cancerous stages (1-4).
Over 200 chemical mammary carcinogens have been experimentally detected to acutely induce
cancerous cells in cultures and tumors in animals at high doses of micro- to milli-molar
concentrations (1,3,5). A high-dose approach may serve as a proper way to study occupational
exposure; however, considering that chronic exposure of human tissues to low doses of
carcinogens is responsible for most human cancers, a chronic, low-dose approach might be a
more proper way to study the environmental exposure most often responsible for human breast
cancer development. A new approach is needed to reveal environmental, mammary carcinogens,
at low and bio-achievable levels, capable of inducing human breast cell carcinogenesis.
We have been developing a model to mimic breast cell carcinogenesis occurring with
accumulated exposures to low doses of environmental carcinogens (6-9). We used the
environmental

carcinogens

4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

(NNK)

and

benzo[a]pyrene (B[a]P) at pico-molar concentrations, like those detected in patients (10-13), to
repeatedly treat immortalized, non-cancerous, human breast epithelial MCF10A cells in culture
to progressively induce acquisition of cancer-associated properties (6-9). NNK is considered one
of the most potent lung carcinogens in tobacco products (14); although gastric administration of
NNK into rats results in DNA-adduct formation in the mammary gland and development of
mammary tumors (14-17), NNK is not currently recognized as a breast carcinogen. B[a]P, a
family member of polycyclic aromatic hydrocarbons, is considered an environmental, dietary,
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and tobacco carcinogen, its metabolites forming strong DNA adducts and causing DNA lesions,
and it is recognized as a mammary carcinogen in rodents (3,4,12,13,18-21). Studies using human
cell lines for genotoxicity tests and studies of adduct formation reveal genotoxic activity of NNK
and B[a]P at concentrations as low as 25 mmol/L and 25 µmol/L, respectively (22). Our cellular
model reveals the ability of NNK and B[a]P, at a bio-achievable level of 100 pmol/L, to
chronically and progressively induce carcinogenesis of MCF10A cells (6-9). Hence, our model
system takes a new, sensitive approach of validating low doses of environmental, mammary
carcinogens in chronic induction of human breast cell carcinogenesis.
It has been shown that a short-term exposure of MCF10A cells to the B[a]P metabolites
B[a]P-quinones at 10 µmol/L for 10 min induces reactive oxygen species (ROS) elevation (23),
and exposure of normal human bronchial epithelial cells to NNK at 1 to 5 µmol/L for 24 h
induces cell proliferation (24). It has been postulated that ROS elevation and cell proliferation
increase cell susceptibility to DNA damage induced by carcinogens, contributing to cellular
carcinogenesis (25,26). The oxidative DNA damage caused by ROS includes strand breaks and
nucleotide modifications, resulting in mutations and contributing to cellular transformation (19).
Activation of the ERK pathway also contributes to cell proliferation and phosphorylation of
histone H2AX (27), the latter of which (on serine 139) is widely used as an indicator for DNA
damage (28). In addition, B[a]P, at high doses ranging from 0.02 to 1 µmol/L, has been shown to
induce cell proliferation and DNA damage in breast adenocarcinoma MCF7 cells (29,30).
However, it is not clear whether pico-molar levels of NNK and B[a]P are able to induce ROS
elevation and cell proliferation in breast cells with short-term exposure, contributing to induction
of carcinogenesis associated with long-term exposure.
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Epidemiologic and experimental studies have shown that various dietary polyphenolic
compounds, which are widely found in vegetables, fruits, and tea, possess anticancer,
antiproliferative, antioxidant, and apoptotic activities (1,31). The use of green tea to increase the
body‟s antioxidant activity is becoming increasingly popular in the Western world (32). A
typical brewed green tea contains 30 to 45% green tea catechins (GTCs), including epicatechin
(EC), epicatechin-3-gallate (ECG), epigallocatechin (EGC), and epigallocatechin-3-gallate
(EGCG) (31). GTCs have been shown to be more effective antioxidants than vitamins C and E
(33), and their order of effectiveness as radical scavengers is ECG > EGCG > EGC > EC (24).
Animal studies show that GTCs are able to suppress rat mammary carcinogenesis induced by
7,12-dimethylbenz[a]anthracene and N-methyl-N-nitrosourea (34,35). Laboratory studies also
have shown that GTCs possess inhibitory and apoptotic activity in the growth of human breast
cancer cells in cultures (36,37). Epidemiological studies have examined the benefits of tea
consumption for breast cancer prevention, and some evidence has indicated that green tea
consumption may help prevent breast cancer recurrence in early stage cancers; however, the
results are controversial (31,38,39). In addition, studies show that EGCG and EGC exhibit higher
toxicity than ECG and EC in inducing cellular DNA damage (40,41). Therefore, additional
studies are needed to clarify the effectivity of individual GTCs, at non-cytotoxic levels, used in
protection of breast cells from carcinogenesis in order to safely and effectively reduce the health
risk of sporadic breast cancer.
Previously, we used our model system to detect the ability of a dietary GTC extract
containing 60% total catechins, at non-cytotoxic concentrations (< 40 µg/mL), to suppress
chronically B[a]P-induced carcinogenesis of breast epithelial cells (8). In this study, we used our
model system to pursue the mechanisms of NNK and B[a]P in inducing breast cell
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carcinogenesis and identify targeted endpoints transiently or constantly induced by short-term
and long-term exposure to both carcinogens, respectively. Then, we used NNK- and B[a]Pinduced endpoints as targets to identify preventive agents capable of intervening in the cellular
carcinogenesis. We identified the essential role of ROS in modulating the ERK pathway leading
to cell proliferation and chromosomal DNA damage in NNK- and B[a]P-induced breast cell
carcinogenesis. We also revealed the preventive activity of individual EC, ECG, EGC, and
EGCG, at non-cytotoxic levels, in suppression of NNK- and B[a]P-induced breast cell
carcinogenesis.

Materials and methods
Cell cultures, reagents, and cellular carcinogenesis
Immortalized, non-cancerous human breast epithelial cell line MCF10A (American Type
Culture Collection [ATCC], Rockville, MD) and derived cell lines were maintained in complete
MCF10A culture medium (CM) (1:1 mixture of DMEM and HAM's F12, supplemented with
100 ng/mL cholera enterotoxin, 10 µg/mL insulin, 0.5 µg/mL hydrocortisol, 20 ng/mL epidermal
growth factor, and 5% horse serum) (6-9). Human breast adenocarcinoma MCF7 cells were
maintained in DMEM supplemented with 10% heat-inactivated fetal calf serum. All cultures
were maintained in medium supplemented with 100 U/mL penicillin and 100 µg/mL
streptomycin in 5% CO2 at 37° C. Stock solutions of NNK (Chemsyn, Lenexa, KS), B[a]P
(Aldrich, Milwaukee, WI), U0126 (Cell Signaling, Beverly, MA), and chloromethyldichlorodihydro-fluorescein-diacetate (CM-H2DCF- DA) (Invitrogen, Carlsbad, CA) were
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prepared in dimethyl sulfoxide and diluted with culture medium for assays. EC, ECG, EGC,
EGCG (Sigma-Aldrich, St. Louis, MO), and N-acetyl-L-cysteine (NAC) (Alexis, San Diego,
CA) were prepared in distilled water and diluted with culture media for assays.

Protocol for induction and suppression of cell carcinogenesis
To chronically induce cell carcinogenesis for intervention, 24 h after each subculturing,
cultures were exposed to combined NNK and B[a]P each at 100 pmol/L in the absence and
presence of individual EC, ECG, EGC, and EGCG for 48 h as one cycle of exposure for 5 to 20
cycles; cultures were subcultured every 3 days (3 days/cycle) (Figure 3.1A).

Assay for reduced dependence on growth factors
The low-mitogen (LM) medium contained reduced total serum and mitogenic additives to
2% of the concentration formulated in CM medium. Five × 103 cells were seeded in 100-mm
culture dishes and maintained in LM medium. Growing cell colonies that reached 0.5 mm
diameter in 10 days were stained with Coomassie brilliant blue and identified as cell clones
acquiring the cancer-associated property of reduced dependence on growth factors.

Assay for anchorage-independent cell growth
The base layer consisted of 2% low-melting agarose (Sigma-Aldrich) in CM medium.
Then, soft-agar consisting of 0.4% low-melting agarose in a mixture (1:1) of CM medium with 3
day-conditioned medium prepared from MCF10A cultures was mixed with 1 × 104 cells and
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plated on top of the base layer in 60-mm diameter culture dishes. Growing colonies that reached
0.1 mm diameter by 20 days were identified as cell clones acquiring the cancer-associated
property of anchorage-independent growth.

Cell mobility-healing assay
Cells were seeded in 6-well plates and grown to confluence in CM medium. Cells were
rinsed with phosphate-buffered saline (PBS) and starved for 15 h in DMEM/Ham‟s F12 media
containing 2% serum (42). The monolayer was then scratched with a 23-gauge needle (BD
Sciences, Franklin Lakes, NJ) to generate wounded areas and rinsed with CM medium to remove
floating cells. Cultures were maintained in CM medium, and the wounded areas were examined
6 h and 24 h after scratches to detect healing of wounded areas. Wound healing area was
calculated by using Total Lab TL100 software (Total Lab, Newcastle, NE).

Cell viability assay
A methyl thiazolyl tetrazolium (MTT) assay kit (ATCC) was used to measure cell growth
and viability in cultures. As described by the manufacturer, 3 × 104 cells were seeded into each
well of 96-well culture plates for 24 h. After treatments, cells were incubated with MTT reagent
for 4 h, followed by incubation with detergent reagent for 24 h. Quantification of reduced MTT
reagent in cultures was determined with an enzyme-linked immunosorbent assay (ELISA) reader
(Bio-Tek, Winooski, VT) at 570 nm.
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Cell proliferation assay
Cell proliferation was determined using the 5-bromo-2-deoxyuridine (BrdU) cell
proliferation ELISA kit (Roche, Indianapolis, IN). Five x 104 cells were seeded into each well of
96-well culture plates. After the indicated treatments, the cells were labeled with BrdU for 12 h,
fixed, incubated with peroxidase-conjugated BrdU-specific antibodies, and stained with the
peroxidase substrate. Quantification of BrdU-labeled cells was determined with an ELISA reader
(Bio-Tek) at 370 nm.

Apoptotic cell death assay
An annexin-V-fluorescein isothiocyanate (FITC) apoptosis detection kit with propidium
iodide (BD Sciences) was used to detect apoptotic cell death by flow cytometry (43). In brief,
cells were collected after trypsinization and washed with PBS. Cells were then incubated with
annexin-V-FITC and propidium iodide in a binding buffer (10 mmol/L Hepes-KOH, pH 7.4, 150
mmol/L NaCl, 1.8 mmol/L CaCl2) for 20 min at ambient temperature in the dark. Flow
cytometric analysis was performed on the Coulter EPICS Elite Cytometer (Hialeah, FL) at the
excitation and emission wavelengths of 488 and 550 nm, respectively, for FITC measurements,
and at 488 and 645 nm for propidium iodide measurements. The percentage of cells undergoing
apoptotic death was determined using Multicycle software (Phoenix, San Diego, CA).
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Measurement of ROS
To measure intracellular ROS levels, cells were incubated with 5 μmol/L CM-H2DCFDA for 1 h (44). Cells were rinsed with Ca++ and Mg++ free PBS, trypsinized from cultures, and
resuspended in PBS for analysis of ROS by flow cytometry, as described above, using a 15 mW,
air-cooled argon laser to produce 488 nm light. DCF fluorescence emission was collected with a
529-nm band pass filter. The mean fluorescence intensity of 2 × 104 cells was quantified using
Multicycle software (Phoneix) .

DNA damage assay
DNA damage was detected with a comet assay. Cells were trypsinized and collected in
PBS at a density of 2 x 104 cells/ml. Cell suspension was mixed with an equal volume of 1%
low-melting agarose (Fisher, Fair Lawn, NJ) and placed on agarose-coated slides. Slides were
then immersed in lysis solution (1.2 M NaCl, 100 mM Na2EDTA, 1% Triton X-100, and 0.3nM
NaOH, pH 13) at 25° C for 1 h. Slides were rinsed 3 times with alkaline buffer (2 mM Na2EDTA
and 300 mM NaOH) for 20 min each. After electrophoresis in the same alkaline buffer at 20V
for 30 min (45), slides were rinsed with distilled water, stained with 2.5 µg/ml of propidium
iodide for 20 min, and examined with a Zeiss fluorescence microscope (Thornwood, NY)
equipped with an excitation filter of 546 nm and barrier filter of 590 nm. Fifty nuclei per slide
were scored for tail moment as a parameter using CometScore software (Tritek, USA).

140

Western immunoblotting
Cells were lysed in a buffer (10 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, 5 mM
EDTA, 10 mM sodium pyrophosphate, 10% glycerol, 0.1% Na3VO4, 50 mM NaF, pH 7.4); cell
lysates were isolated from the supernatants after centrifugation of crude lysates at 20,000 g for
20 min (7,8). Protein concentration in cell lysates was measured using the BCA assay (Pierce,
Rockford, IL). Equal amounts of cellular proteins were resolved by electrophoresis in 10% or
14% SDS-PAGE and transferred to nitrocellulose filters for Western immunoblotting as
described previously (9). Antibodies specific to Erk1/2 and β-actin were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). Antibodies specific to phosphorylated Erk1/2 (p-Erk1/2),
phosphorylated H2AX (p-H2AX), H2AX, phosphorylated Mek1/2 (p-Mek1/2), and Mek1/2
were purchased from Cell Signaling Technology. Antigen-antibody complexes on filters were
detected by the Supersignal chemiluminescence kit (Pierce).

Statistical analysis
To statistically verify the cytotoxicity of EC, ECG, EGC, and EGCG, the Shapiro-Wilk
test (46) was used to assess normality of cell viability, cell proliferation, and apoptosis. None of
the variables showed evidence of lack of normality (P > 0.05). Therefore, the Student t test was
used to compare each of the catechins at each of the concentrations (10, 40, and 100 µg/mL) with
the control. Adjustments for multiple comparisons were performed using the Simes method (47).
To statistically verify the suppression of NNK- and B[a]P-induced carcinogenesis by
individual catechins, a one-way analysis of variance (ANOVA) test was used to establish
significant difference between various treatment groups; a P value of < 0.05 was considered
141

significant. Then, a pairwise analysis of dependent variables was performed with the Duncan
multiple range test to verify the significance of differences between groups.
Statistical significance of all the other studies was analyzed by the Student t test; α levels
were adjusted by the Simes method (47). A P value of <0.05 was considered significant.
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Results
NNK- and B[a]P-induced cellular carcinogenesis
Growth factors are required for normal cells to grow and survive, and cell adhesion to
extracellular matrixes is important for cell survival in a multi-cell environment; aberrantlyincreased cell survivability acquired to reduce dependence on growth factors and to promote
anchorage-independent growth can lead cells to tumorigenic transformation (48,49). We used
these two important cancer-associated properties as long-term, targeted endpoints for measuring
the ability of NNK and B[a]P to induce carcinogenesis of human breast cells. As shown in
Figure 3.1A, we repeatedly exposed MCF10A cells, for 5, 10, 15, and 20 cycles, to individual or
combined NNK and B[a]P each at a bio-achievable concentration of 100 pmol/L, which can be
detected in body fluids and tissues of cancer patients and tobacco users (11-13). We detected that
accumulated exposures to individual or combined NNK and B[a]P resulted in increasing
acquisition of the cancer-associated properties of reduced dependence on growth factors (Figure
3.1B) and anchorage-independent growth (3.1C) in an exposure-dependent manner, particularly
for 5 and 10 cycles. Although accumulated exposures to carcinogens for 20 cycles resulted in
higher levels of acquired cancer-associated properties than 10 and 15 exposure cycles, the
increased levels appeared to be modest. NNK and B[a]P exhibited comparable abilities to
progressively induce breast cell carcinogenesis, and the combination of NNK and B[a]P
additively increased degrees of acquired cancer-associated properties. Because cumulative
exposures to combined NNK and B[a]P for 10 cycles efficiently and additively induced cellular
carcinogenesis versus individual carcinogens, we combined carcinogens each at 100 pmol/L in
our extended studies.
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Short-term targeted endpoints: ROS elevation, the ERK pathway, cell proliferation, and
DNA damage transiently induced by short-term exposure to NNK and B[a]P
To pursue the mechanisms of NNK and B[a]P in inducing breast cell carcinogenesis, we
studied the activityof combined NNK and B[a]P each at 100 pmol/L to induce ROS elevation,
cell proliferation, DNA damage, and the cell proliferation-related ERK pathway in each shortterm exposure. As shown in Figure 3.2A, combined NNK and B[a]P at 100 pmol/L induced
ROS elevation and cell proliferation. A transient elevation of ROS after NNK and B[a]P
treatment was followed by a transient induction of the ERK pathway indexed by phosphorylation
of Erk1/2 (Figure 3.2B); carcinogen-induced ROS reached its maximal level by 16 h, but Erk1/2
phosphorylation did not reach its maximal level until 24 h. ROS elevation appeared to be
induced prior to activation of the ERK pathway during short-term exposure to NNK and B[a]P.
To address whether ROS elevation cross-talked with the ERK pathway, we used the antioxidant
NAC (28) to block ROS and the Mek1/2 inhibitor U0126 to block the ERK pathway (50). We
detected that NAC treatment significantly reduced NNK- and B[a]P-induced, ROS elevation, cell
proliferation, and phosphorylation of Mek1/2 and Erk1/2 (Figure 3.2C). However, blockage of
the ERK pathway did not affect NNK- and B[a]P-induced ROS elevation but reduced cell
proliferation (Figure 3.2D). These results indicate that NNK- and B[a]P-induced ROS elevation
played a role in modulating the ERK pathway for cell proliferation.
To investigate whether NNK- and B[a]P-induced ROS and the ERK pathway were
involved in DNA damage, we used a comet assay (51) to detect the extent of nuclear DNA
damage by quantifying the DNA damage-produced comet tail moment in agarose gel
electrophoresis. We detected that exposure of cells to NNK and B[a]P induced significant DNA
damage and H2AX phosphorylation, and blockage of ROS elevation or the ERK pathway
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reduced carcinogen-induced DNA damage and H2AX phosphorylation (Figure 3.2E), indicating
that ROS elevation and ERK pathway activation led to DNA damage during cell exposure to
NNK and B[a]P. Thus, cell proliferation, ROS elevation, ERK pathway activation, and DNA
damage should be considered as short-term biological, biochemical, and molecular targeted
endpoints for measuring the activity of NNK and B[a]P in inducing cellular carcinogenesis.

Cytotoxicity of EC, ECG, EGC, and EGCG
Studies showed that EGCG and EGC are more toxic than ECG and EC in inducing
cellular DNA damage (40,41). Whether the cytotoxicity of EC, ECG, EGC, and EGCG
contributes to their preventive activity in intervention of cellular carcinogenesis needs to be
clarified. To determine the cytotoxicity of individual green tea catechins to breast cells, we
investigated the effects of EC, ECG, EGC, and EGCG at various concentrations on viability,
proliferation, and apoptotic death of MCF10A cells. As shown in Figure 3.3, we detected that
none of these catechins at 10 µg/mL showed any detectable effects on reducing cell viability
(3.3A), inhibiting cell proliferation (3.3B), or inducing apoptosis (3.3C). EC at 40 µg/mL also
failed to induce any detectable cytotoxic effects on MCF10A cells, but EC at 100 µg/mL induced
a modest inhibition of cell proliferation and modest apoptosis. ECG, EGC, and EGCG at 40 and
100 µg/mL induced reduction of cell viability (3.3A), inhibition of cell proliferation (3.3B), and
apoptosis (3.3C), in a dose-dependent manner. Analysis of these data indicated distinct
cytotoxicities of these catechins to MCF10A cells: EC < ECG < EGC < EGCG. At 10 µg/mL,
these catechins were non-cytotoxic to MCF10A cells.
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Catechin suppression of NNK- and B[a]P-induced short-term targeted endpoints in
MCF10A cells
To detect whether individual catechins EC, ECG, EGC, and EGCG were able to
counteract against NNK and B[a]P, we studied the activity of these catechins to block NNK- and
B[a]P-increased, short-term targeted endpoints. We exposed MCF10A cells to NNK and B[a]P
in the presence and absence of individual catechins at 10 µg/mL for 24 h. As shown in Figure
3.4, co-treatment with EC, ECG, EGC, and EGCG reduced the NNK- and B[a]P-induced ROS
elevation (3.4A), Erk1/2 phosphorylation (3.4B), cell proliferation (3.4C), and DNA damage
(3.4D) as well as H2AX phosphorylation (3.4E). Apparently, these catechins, at non-cytotoxic
concentrations, were able to suppress ROS elevation, the ERK pathway, cell proliferation, and
DNA damage in non-cancerous breast MCF10A cells. ECG appeared to be more effective than
other catechins in reducing these NNK- and B[a]P-induced, short-term biological, biochemical,
and molecular targeted endpoints.

Catechin suppression of NNK- and B[a]P-induced short-term targeted endpoints in MCF7
cells
To investigate whether catechin suppression of the NNK- and B[a]P-induced, short-term
targeted endpoints of ROS elevation, ERK pathway activation, cell proliferation, and DNA
damage was or was not limited to MCF10A cells, we treated human breast cancer MCF7 cells to
NNK and B[a]P in the absence and presence of individual catechins for 24 h. We detected that
co-treatment with EC, ECG, EGC, and EGCG reduced the NNK- and B[a]P-induced ROS
elevation (Figure 3.5A), ERK1/2 phosphorylation (3.5B), cell proliferation (3.5C), and H2AX
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phosphorylation (3.5D). These results indicated that exposure to NNK and B[a]P also induced
short-term targeted endpoints in breast cancer cells. Catechins, at non-cytotoxic levels, were also
able to suppress NNK- and B[a]P-induced short-term targeted endpoints in cancer MCF7 cells;
ECG appeared to be more effective than other catechins. The results indicate that the ability of
NNK and B[a]P to induce short-term targeted endpoints and the activity of catechin in
suppression of the NNK- and B[a]P-induced short-term targeted endpoints was not limited to
MCF10A cells.

Catechin suppression of chronically NNK- and B[a]P-induced carcinogenesis
To investigate the preventive activity of individual catechins in intervention of breast cell
carcinogenesis chronically induced by cumulative exposures to NNK and B[a]P, we repeatedly
exposed MCF10A cells to NNK and B[a]P in the absence and presence of individual EC, ECG,
EGC, and EGCG at 10 µg/mL for 10 cycles, resulting in the NB, NB/EC, NB/ECG, NB/EGC,
and NB/EGCG cell lines, respectively. In addition to the cancer-associated properties of reduced
dependence on growth factors and anchorage-independent growth, we also investigated the
cancer-associated property of increased cell mobility (52) as the third long-term targeted
endpoint to measure carcinogen-induced and catechin-suppressed cellular carcinogenesis. We
detected that EC, ECG, EGC, and EGCG effectively suppressed NNK- and B[a]P-induced
cellular acquisition of reduced dependence on growth factors (Figure 3.6A) as well as
anchorage-independent growth (3.6B). Not only the numbers but also sizes of colonies were
suppressed by catechins (3.6A and 3.6B). The results also revealed that ECG exhibited higher
activity than other catechins in suppression of carcinogen-induced cellular acquisition of these
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two cancer-associated properties. Using the scratch/wound assay (42), we detected that NB cells
acquired higher mobility than parental MCF10A cells to heal the wounded areas, and NB/EC and
NB/EGCG cells exhibited higher mobility than NB/ECG and NB/EGC cells to heal the wounded
areas (Figure 3.6C). Analysis of healing rates revealed that NB/ECG cells exhibited a lower
mobility than NB, NB/EGC, NB/EC, and NB/EGCG cells (Figure 3.6D), indicating that ECG
possessed higher activity than other catechins in suppression of carcinogen-induced cellular
acquisition of increased mobility. The high effectivity of ECG in suppressing cellular
carcinogenesis was correlated with its activity in blocking ROS elevation and ERK pathway
activation, which were transiently-induced by short-term exposure to NNK and B[a]P.
To validate the contributing roles of ROS elevation and the ERK pathway in cellular
carcinogenesis induced by cumulative exposures to NNK and B[a]P, we repeatedly exposed
MCF10A cells to NNK and B[a]P in the presence of NAC to block ROS, or U0126 to block the
ERK pathway for 10 cycles. We detected that blockage of ROS elevation or ERK pathway
activation during each cycle of exposure resulted in significant suppression of NNK- and B[a]Pinduced cellular acquisition of reduced dependence on growth factors and anchorageindependent growth (Figure 3.6E), verifying the contributing roles of ROS elevation and ERK
pathway activation in NNK- and B[a]P-induced cellular carcinogenesis.
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Discussion
Our model system addresses breast cell carcinogenesis induced by chronic exposure to
carcinogens at bio-achievable levels and identifies preventive agents, at non-cytotoxic levels,
capable of suppressing chronically-induced breast cell carcinogenesis. We demonstrated, for the
first time, a two-step strategy. The first step initially uses short-term biological, biochemical, and
molecular targeted carcinogenic endpoints transiently induced by short-term exposure to
carcinogens for detecting preventive agents capable of blocking cellular carcinogenesis. The
second step subsequently uses long-term biological, biochemical, and molecular targeted
carcinogenic endpoints induced by chronic exposure to carcinogens to verify preventive agents
effective in suppression of cellular carcinogenesis.
Our studies revealed that cumulative exposures to NNK and/or B[a]P at a bio-achievable
concentration of 100 pmol/L resulted in progression of human breast cells to increasingly acquire
cancer-associated

properties

in

an

exposure-dependent

manner,

without

acquiring

tumorigenicity. Although cellular acquisition of tumorigenicity is regarded as the gold standard
for validating cell malignancy, many human cancer cells are not tumorigenic, such as MDA-MB453 (53) and urinary bladder cancer J82 cells (54). Previously, we showed that cumulative
exposures of MCF10A cells to NNK and B[a]P at 100 pmol/L for 20 cycles induce the cancerassociated property of acinar-conformational description with irregular spheroids developed on
Matrigel (9). Acinar structures with a hollow lumen and apicobasally polarized cells are
important characteristics found in glandular epithelia in vivo; the disruption of an intact
glandular structure is a hallmark of epithelial cancer, even at its earliest premalignant stages,
such as ductal carcinoma in-situ (DCIS) (55-57). Clinically, breast cells involved in DCIS are not
malignant and have not acquired the ability to invade adjacent tissues through the ductal or
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lobular wall, but often premalignant cells can either develop into malignant cells or increase the
risk of becoming malignant (4,58,59). Thus, in addition to tumorigenicity, using various cancerassociated properties as measurable targeted endpoints should be seriously considered in
studying cellular carcinogenesis and intervention of cellular carcinogenesis.
Short-term exposure to NNK and B[a]P at 100 pmol/L induced transient ROS elevation
leading to ERK pathway activation, cell proliferation, and chromosomal DNA damage.
However, these short-term targeted endpoints were transient; they were not permanent in cells
acquiring cancer-associated properties induced by cumulative exposures to NNK and B[a]P. In
our previous studies, we detected that the ERK pathway is downregulated in two individual cell
clones isolated from cultures after long-term exposure to NNK (6), and cell proliferation is not
increased in cultures after long-term exposure to NNK and/or B[a]P (7-9). Aiming at these
transiently-induced, short-term targeted endpoints, we detected green tea catechins EC, ECG,
EGC, and EGCG, at a non-cytotoxic concentration of 10 µg/mL, were capable of blocking NNKand B[a]P-induced ROS elevation, ERK pathway activation, cell proliferation, and DNA damage
to various extents in not only non-cancerous MCF10A, but also in adenocarcinoma MCF7 cells.
Comparing these catechins at 10 µg/mL revealed that ECG (22.6 µmol/L) was more effective
than EC (34.5 µmol/L), EGC (32.7 µmol/L), and EGCG (21.8 µmol/L) to block these short-term
targeted carcinogenic endpoints. Interestingly, ECG was also more effective than EC, EGC, and
EGCG in suppression of cellular carcinogenesis, measured by degrees of acquired cancerassociated properties in long-term targeted carcinogenic endpoints, permanently induced by
cumulative exposures to NNK and B[a]P; however, whether the activity of individual catechins
may vary in suppression of cellular carcinogenesis induced by other carcinogens remains to be
addressed. In addition, ECG was less cytotoxic to MCF10A cells than EGCG and EGC. Studies
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of the hepatotoxicity of GTCs in rats showed that EGCG is the most toxic of all four catechins;
for example, the LD50 for EGCG (200 µM) was 10 times lower than that for ECG (2000 µM),
indicating that ECG is much less toxic than EGCG (60). Thus, the cytotoxicity-independent
ability of these catechins to block NNK- and B[a]P-induced, ROS elevation, ERK pathway
activation, cell proliferation, and DNA damage in each short-term exposure accounted for their
effectiveness in suppression of breast cell carcinogenesis induced by long-term, accumulated
exposures to NNK and B[a]P. In addition, in our previous studies, we detected that the NNKand B[a]P-bioactivating, cytochrome P-450 enzymes CYP1A1 and CYP1B1 are elevated in cells
exposed to NNK and B[a]P, and grape seed proanthocyanidin extract is able to reduce these
activating enzymes (9). However, we did not detect any activity of GTCs in suppressing NNKand B[a]P-induced CYP1A1 or CYP1B1 (data not shown).
NNK- and B[a]P-induced ROS elevation played a key role in activation of the ERK
pathway, leading to cell proliferation and DNA damage. Studies have shown that ROS is able to
induce the ERK pathway via activation of membrane-associated growth factor receptors or via
Raf-independent Mek1/2 activation (61,62). In our studies, exposure of MCF10A cells to NNK
and B[a]P did not induce any detectable upregulation of Ras or Raf, both of which are upstream
from Mek1/2 and Erk1/2 (data not shown). Thus, NNK- and B[a]P-elevated ROS induced the
ERK pathway in a Raf-independent manner. However, how ROS was induced by NNK and
B[a]P in MCF10A and MCF7 cells, and how ROS was able to induce Raf-independent activation
of Mek1/2 and Erk1/2 remain to be determined. Prevention of human breast cell carcinogenesis
associated with chronic exposure to low doses of environmental carcinogens is an underinvestigated area. Our model system presents unique features of mimicking chronically-induced
carcinogenesis of human breast cells to increasingly acquire cancer-associated properties induced
151

by chronic, cumulative exposures to carcinogens at low concentrations in the pico-molar range,
as in environmental exposure. In contrast, many cell systems have been developed to study the
activity of carcinogens at high concentrations in the micro-molar range, as in occupational
exposure, in acute induction of cellular carcinogenesis (2-5,18-21). Using our cellular model as a
target system, we are able to verify the preventive activity of individual green tea catechins at
non-cytotoxic levels in suppression of chronic cellular carcinogenesis and identify the
mechanisms for catechins in counteracting the biological, biochemical, and molecular effects of
NNK and B[a]P. Use of non-cytotoxic catechin components should be seriously considered in
prevention of cellular carcinogenesis induced by chronic exposure to environmental carcinogens.
Using our model system will conceivably accelerate the identification of additional preventive
agents that are effective in reducing the health risk of sporadic breast cancer associated with
chronic exposure to carcinogens present in environmental pollution.
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Figure. 3.1. NNK- and B[a]P-induced cellular carcinogenesis. (A) MCF10A cultures were
repeatedly exposed to individual (N, B) or combined NNK and B[a]P (NB) each at 100 pmol/L
for 5, 10, 15, and 20 cycles. (B) To determine cellular acquisition of the cancer-associated
property of reduced dependence on growth factors (RDGF), cells were maintained in LM
medium for 10 days. Cell colonies (≥ 0.5 mm diameter) were counted. (C) To determine cellular
acquisition of the cancer-associated property of anchorage-independent growth (AIG), cells were
seeded in soft-agar for 20 days. Cell colonies (≥ 0.1 mm diameter) were counted. Relative
degrees of the cancer-associated properties of RDGF and AIG acquired by carcinogen-exposed
cells were determined by normalizing with the colony numbers of vehicle-treated counterpart
MCF10A cells, set as 1 (X, arbitrary unit), in each exposure cycle. Columns, mean of triplicates;
bars, SD. All results are representative of at least 3 independent experiments. Mean colony
numbers in each treatment group were analyzed by one-way ANOVA at P < 0.05 to indicate
significant difference in number of colonies in various groups. To further determine the
significant difference between individual groups, a pairwise analysis of variables was performed
using the Duncan multiple range test. Columns with different superscript letters (a, b, c, d, e, f,
and g) indicate significant difference at P < 0.05 between groups; no significant difference was
seen between groups with the same superscript.
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Figure. 3.1.
NNK- and B[a]P-induced cellular carcinogenesis.
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Figure. 3.2. Short-term targeted endpoints: ROS elevation, the ERK pathway, cell
proliferation, and DNA damage transiently induced by short-term exposure to NNK and
B[a]P. (A) MCF10A cells were exposed to combined NNK and B[a]P (NB) each at 100 pmol/L
for 24 h. (B) MCF10A cells were exposed to NB for 0, 4, 8, 16, 24, and 48 h. (C, D, and E)
MCF10A cells were exposed to NB in the presence or absence of 5 mmol/L NAC or 10 µmol/L
U0126 (U0) for 24 h. (A, B, C, and D) ROS levels were measured with CM-H2DCF-DA
labeling; relative level of ROS as fold induction was normalized by the level determined in
untreated counterpart cells, set as 1 (X, arbitrary unit). (A, C, and D) Cell proliferation was
determined; relative cell growth rate was normalized by the value of BrdU detected in untreated
counterpart cells, set as 1 (X, arbitrary unit). (B, C, D, and E) Cell lysates were prepared and
analyzed by Western immunoblotting to detect levels of phosphorylated Mek1/2 (p-Mek1/2),
Mek1/2, p-Erk1/2, Erk1/2, p-H2AX, and H2AX, with β-actin as a control, and these levels were
quantified by densitometry. The levels of specific phosphorylation of Mek1/2 (p-Mek), Erk1/2
(p-Erk), and H2AX (p-H2AX) were calculated by normalizing the levels of p-Mek1/2, p-Erk1/2,
and p-H2AX with the levels of Mek1/2, Erk1/2, and H2AX, respectively, and then further
normalizing with the β-actin level and the level set in untreated cells (lane1) as 1 (X, arbitrary
unit). (E) DNA damage was measured by a comet assay in 50 cells per treatment; relative DNA
damage was normalized by the value determined in untreated counterpart cells, set as 1 (X,
arbitrary unit). Representative images of cells treated in the comet assay are shown. Columns,
mean of triplicates; bars, SD. All results are representative of at least 3 independent experiments.
The Student t test was used to analyze statistical significance, indicated by * P < 0.05, ** P <
0.01, *** P < 0.001; α levels were adjusted by the Simes method.
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Figure. 3.2.
Short-term targeted endpoints: ROS elevation, the ERK pathway, cell proliferation, and
DNA damage transiently induced by short-term exposure to NNK and B[a]P.
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Figure. 3.3. Cytotoxicity of EC, ECG, EGC, and EGCG. MCF10A cells were treated with 0,
10, 40 and 100 µg/mL of EC, ECG, EGC, and EGCG individually for 48 h. (A) Quantification of
cell viability was determined with an MTT assay kit, and relative cell viability was normalized
by the value determined in untreated counterpart cells, set as 100%. (B) Cell proliferation was
determined; relative cell growth rate was normalized by the value of BrdU detected in untreated
cells, set as 100%. (C) Apoptotic cell population (%) was measured by flow cytometry with an
Annexin-V-FITC Apoptosis Detection Kit. Columns, mean of triplicates; bars, SD. All results
are representative of at least 3 independent experiments. The Student t test was used to analyze
statistical significance, indicated by * P < 0.05, ** P < 0.01, *** P < 0.001; α levels were
adjusted by the Simes method.
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Figure. 3.3.
Cytotoxicity of EC, ECG, EGC, and EGCG.
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Figure. 3.4. Catechin suppression of NNK- and B[a]P-induced short-term targeted
endpoints in MCF10A cells. MCF10A cells were exposed to combined NNK and B[a]P (NB)
each at 100 pmol/L in the absence or presence of 10 µg/mL of EC, ECG, EGC, and EGCG for
24 h. (A) ROS levels were measured with CM-H2DCF-DA labeling; relative level of ROS as
fold induction was normalized by the level determined in untreated counterpart cells, set as 1 (X,
arbitrary unit). (B and E) Cell lysates were prepared and analyzed by Western immunoblotting to
detect levels of p-Erk1/2, Erk1/2, p-H2AX, and H2AX, with β-actin as a control, and these levels
were quantified by densitometry. The levels of specific phosphorylation of Erk1/2 (p-Erk) and
H2AX (p-H2AX) were calculated by normalizing the levels of p-Erk1/2 and p-H2AX with the
levels of Erk1/2 and H2AX, respectively, and then further normalizing with β-actin level and the
level set in untreated cells (lane1) as 1 (X, arbitrary unit). (C) Cell proliferation was determined;
relative cell growth rate was normalized by the value of BrdU detected in untreated counterpart
cells, set as 1 (X, arbitrary unit). (D) DNA damage was measured by comet assay; relative DNA
damage was normalized by the value determined in untreated counterpart cells, set as 1 (X,
arbitrary unit). Columns, mean of triplicates; bars, SD. All results are representative of at least 3
independent experiments. The Student t test was used to analyze statistical significance,
indicated by ** P < 0.01, *** P < 0.001; α levels were adjusted by the Simes method.
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Figure. 3.4.
Catechin suppression of NNK- and B[a]P-induced short-term targeted endpoints in
MCF10A cells.
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Figure. 3.5. Catechin suppression of NNK- and B[a]P-induced short-term targeted
endpoints in MCF7 cells. MCF7 cells were exposed to combined NNK and B[a]P (NB) each at
100 pmol/L in the absence or presence of 10 µg/mL of EC, ECG, EGC, and EGCG for 24 h. (A)
ROS levels were measured with CM-H2DCF-DA labeling; relative level of ROS as fold
induction was normalized by the level determined in untreated counterpart cells, set as 1 (X,
arbitrary unit). (B and D) Cell lysates were prepared and analyzed by Western immunoblotting to
detect levels of phosphorylated Erk1/2 (p-Erk1/2), Erk1/2, p-H2AX, and H2AX, with β-actin as
a control, and these levels were quantified by densitometry. The levels of specific
phosphorylation Erk1/2 (p-Erk) and H2AX (p-H2AX) were calculated by normalizing the levels
of p-Erk1/2 and p-H2AX with the levels of Erk1/2 and H2AX respectively, and then further
normalizing with β-actin level and the level set in untreated cells (lane1) as 1 (X, arbitrary unit).
(C) Cell proliferation was determined; relative cell growth rate was normalized by the value of
BrdU detected in untreated counterpart cells, set as 1 (X, arbitrary unit). Columns, mean of
triplicates; bars, SD. All results are representative of at least 3 independent experiments. The
Student t test was used to analyze statistical significance, indicated by ** P < 0.01, *** P <
0.001; α levels were adjusted by the Simes method.
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Figure. 3.5.
Catechin suppression of NNK- and B[a]P-induced short-term targeted endpoints in MCF7
cells.
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Figure. 3.6. Catechin suppression of chronically NNK- and B[a]P-induced carcinogenesis.
(A-D) MCF10A cultures were repeatedly exposed to combined NNK and B[a]P (NB) each at
100 pmol/L in the presence of 10 µg/mL of EC, ECG, EGC, and EGCG (NB/catechin) for 10
cycles. (E) MCF10A cultures were repeatedly exposed to NB in the presence of 5 mmol/L NAC
or 10 µmol/L U0126 (U0) for 10 cycles. (A and E) To detect effectivity of individual catechins,
NAC, and U0 on suppression of cellular acquisition of reduced dependence on growth factors
(RDGF), 5 × 103 cells were seeded and maintained in LM medium for 10 days. (B and E) To
detect effectivity of individual catechins, NAC, or U0 on suppression of cellular acquisition of
anchorage-independent growth (AIG), 1 × 104 cells were seeded in soft-agar for 20 days. The
value of the suppression effectivity of individual catechins on NB-induced RDGF (A and E) and
AIG (B and E) was calculated by: {1 − [(# of NB/catechin-induced cell colonies) − (# of
MCF10A cell colonies)] ÷ [(# of NB-induced cell colonies) − (# of MCF10A cell colonies)]} x
100 (%). The Student t test was used to analyze statistical significance, indicated by *** P <
0.001; α levels were adjusted by the Simes method. Tables show colony numbers, average
colony size, and range of colony size. Mean colony numbers in each treatment group were
analyzed by one-way ANOVA at P < 0.001 to indicate significant difference in number of
colonies in various groups. To further determine the significant difference between individual
groups, a pairwise analysis of variables was performed using the Duncan multiple range test.
Means with different superscript letters (a, b, c, d, and e) indicate significant difference at P <
0.001 between groups; no significant difference was seen between groups with the same
superscript. (C) To detect effectivity of individual catechins in suppressing carcinogen-induced
cellular acquisition of increased mobility, cells were seeded in CM medium and grown to
confluence (a), a linear area of cell layer was removed from each culture with a 23-gauge needle
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to produce wounded cultures, and the wounded areas were examined (×100 magnification) 6 (b)
and 24 h (c) after wounding. Arrows indicate width of wounded areas. Results are representative
of 3 independent experiments. (D) To quantitatively measure cell mobility detected in (C), the
area not healed by the cells was subtracted from total area of initial wound to calculate the
wound healing area (%) at time intervals of 6 h (white columns) and 24 h (grey columns).
Columns, mean of triplicates; bars, SD. All results are representative of 3 independent
experiments. The Student t test was used to analyze statistical significance, indicated by * P <
0.05, ** P < 0.01; α levels were adjusted by the Simes method.
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Figure. 3.6.
Catechin suppression of chronically NNK- and B[a]P-induced carcinogenesis.
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PART –IV

Mesenchymal and stem-like cell properties targeted by green
tea and grape seed extract in suppression of chronic breast
cell carcinogenesis
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Abstract
Cancer stem-like cells and the epithelial-to-mesenchymal transition (EMT) are postulated
to play roles in various stages of cancer development, but their roles in chronic breast cell
carcinogenesis remain to be clarified. Here, we investigated the roles of properties and markers
associated with stem-like cells and the EMT in carcinogenesis chronically induced by chemical
carcinogens, as well as their roles in intervention of carcinogenesis by dietary components. We
repeatedly treated immortalized, non-cancerous, human breast epithelial MCF10A cells with
pico-molar concentrations of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and
benzo[a]pyrene (B[a]P) in culture to progressively induce acquisition of cancer-associated
properties, stem-like cell- and EMT-associated properties and markers. We used dietary green
tea catechins (GTC) and grape seed proanthocyanidin extract (GSPE), at non-cytotoxic
concentrations, in intervention of these associated properties and markers. We detected that
cumulative exposures to low doses of NNK and B[a]P resulted in cellular acquisition of stemlike cell- and EMT-associated properties and markers in addition to cancer-associated properties.
The stem-like cell-associated properties and markers included increases in mammosphere
formation, and in aldehyde dehydrogenase-positive and CD44+/CD24- cell populations. The
EMT-associated properties and markers included mesenchymal cell morphology; increased cell
migration, invasion, and mobility; and changed expression of E-Cadherin, EpCAM, Vimentin,
and MMP-9. We also detected that non-cytotoxic GTC and GSPE were effective at intervening
in cellular acquisition of stem-like cell- and EMT-associated properties and markers induced by
NNK and B[a]P. Thus stem-like cell- and EMT-associated properties and markers could be
considered as new targets to use in identifying induction and intervention of breast cell
carcinogenesis.
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Introduction
Carcinogenesis of human breast epithelial cells from non-cancerous to pre-malignant and
malignant stages is a multiyear, multistep, and multipath disease process involving cumulative
genetic and epigenetic alterations [1, 2]. More than 85% of breast cancers are sporadic and
attributable to long-term exposure to environmental factors, such as chemical carcinogens [1-5].
Over 200 chemical carcinogens have been experimentally detected to acutely induce malignancy
in breast cells in cultures or mammary tumors in animals [1,3,6]. These carcinogens have been
studied at high doses of micro- to milli-molar concentrations [1,3,6], which is appropriate in
examining occupational exposure. However, considering that carcinogenesis of human tissues
involves long-term exposure to environmental carcinogens at low doses, a high-dose approach
may not serve as a proper way to study environmental exposure. Thus, it is imperative to take a
chronic, low-dose approach to reveal environmental mammary carcinogens, at physiologicallyachievable levels, capable of inducing human breast cell carcinogenesis.
Our chronic carcinogenesis model has revealed that at physiologically-achievable picomolar concentrations [7-10], two environmental carcinogens 4-(methylnitrosamino)-1-(3pyridyl)-1-butanone (NNK) and benzo[a]pyrene (B[a]P) are capable of inducing carcinogenesis
of immortalized, non-cancerous, human breast epithelial MCF10A cells [11-15]. NNK is
considered one of the most potent lung carcinogens in tobacco products [16]; although gastric
administration of NNK into rats results in DNA-adduct formation in the mammary gland and
development of mammary tumors [16-19], NNK is not currently recognized as a breast
carcinogen. B[a]P, a family member of polycyclic aromatic hydrocarbons, is considered an
environmental, dietary, and tobacco carcinogen. Its metabolites form strong DNA adducts and
cause DNA lesions, and B[a]P is recognized as a mammary carcinogen in rodents [1,4,10,20-23].
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In our model [11-15], 24 h after each subculturing, MCF10A cultures receive 48-h cycles of
exposure to NNK and B[a]P. Although in immune-deficient mice, cells repeatedly exposed to
100 pmol/L NNK and B[a]P each for 20 cycles do not form xenograft tumors, the cumulative
exposures result in cellular acquisition of progressively-increased degrees of various cancerassociated properties, including reduced dependence on growth factors, anchorage-independent
growth, and acinar-conformational disruption in an exposure cycle-dependent manner. Hence,
our cell model system, which admits development of measurable cancer-associated properties, is
highly valuable for sensitive detection of whether low doses of carcinogens are capable of
inducing non-tumorigenic, premalignant carcinogenesis of breast cells.
Using our model, we have detected that non-cytotoxic concentrations of green tea
catechins (GTC) and grape seed proanthocyanidin extract (GSPE) are effective, in a dosedependent manner, in intervention of NNK- and B[a]P-induced cellular carcinogenesis. This
effectiveness is measured by their ability to suppress the carcinogen-induced, biological targeted
endpoints of reduced dependence on growth factors, anchorage-independent growth, and acinarconformational disruption [12-15]. GTC has been shown to possess inhibitory and apoptotic
activity in human breast cancer cells in cultures [24, 25], and GTC is able to suppress mammary
carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and N-methyl-N-nitrosourea in rats
[26, 27]. Although the results of epidemiological studies are controversial, some evidence has
indicated that green tea consumption may help prevent breast cancer recurrence in early stage
cancers [28, 29]. GSPE has been shown to exhibit antioxidant and anticancer activities in both in
vitro and in vivo models [30–33], and it shows diet-dependent, chemopreventive activity in
suppression of mammary tumors induced by 7,12-dimethylbenz[a]anthracene in rats [33].
Several epidemiological studies suggests benefits of consumption of grapes in prevention of
181

human cancers, including breast [34], bone [35], and oral cancer [36]. Thus, it is important to
further understand the preventive activity of GTC and GSPE in intervention of premalignant,
breast cell carcinogenesis chronically induced by environmental carcinogens. Particularly,
understanding the preventive activity of non-cytotoxic GTC and GSPE will be highly valuable to
targeted intervention of premalignant carcinogenesis to reduce the health risk of sporadic breast
cancer.
It has been postulated that cancer stem-like cells are involved in generating and
maintaining premalignant and malignant lesions [37-39], and development of stem-like cells may
involve induction of the epithelial-to-mesenchymal transition (EMT) program [40]. However, it
is not clear whether cancer stem-like cells and the EMT program can be induced by long-term
exposure to low doses of carcinogens like that in chronic breast cell carcinogenesis. Whether
preventive agents, like GTC and GSPE, are able to suppress the induction of cancer stem-like
cells and the EMT program also remains to be clarified.
In this communication, we investigated stem-like cell- and EMT-associated properties
and markers progressively induced by chronic exposure of breast epithelial cells to NNK and
B[a]P. We also used stem-like cell- and EMT-associated properties and markers as targeted
endpoints to verify the activity of non-cytotoxic GTC and GSPE in suppression of NNK- and
B[a]P-induced cellular carcinogenesis. Thus, the measurable, stem-like cell- and EMT-associated
properties and markers should be considered as new cancer-associated indicators and targeted
endpoints for detecting breast cell carcinogenesis and suppression of progression.
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Materials and Methods
Cell cultures and reagents
Immortalized, non-cancerous, human breast epithelial MCF10A (American Type Culture
Collection [ATCC], Rockville, MD) and derived cell lines were maintained in complete
MCF10A (CM) medium (1:1 mixture of DMEM/Ham‟s F12, supplemented with 100 ng/ml
cholera enterotoxin, 10 μg/ml insulin, 0.5 μg/ml hydrocortisol, 20 ng/ml epidermal growth
factor, and 5% horse serum) as well as 100 U/ml penicillin and 100 μg/ml streptomycin in 5%
CO2 at 37° C [6-9]. All cultures were maintained in 5% CO2 at 37°C. Stock aqueous solutions of
NNK (Chemsyn, Lenexa, KS) and B[a]P (Aldrich, Milwaukee, WI) were prepared in DMSO and
diluted with culture medium for assays. GTC (Polyphenon-60, a mixture of polyphenolic
compounds containing 60% total catechins, Sigma, St. Louis, MO) and GSPE (contains 74%
proanthocyanidins, InterHealth Nutraceuticals, Benicia, CA) were prepared in distilled water and
diluted with medium.

Induction and suppression of cell carcinogenesis
Twenty-four hours after each subculturing, MCF10A cells were treated with combined
NNK and B[a]P each at 100 pmol/L in the absence and presence of GTC or GSPE for 48 h as
one cycle of exposure for 20 cycles; cultures were subcultured every 3 d.

Reduced dependence on growth factors assay
The low-mitogen (LM) medium contained total serum and mitogenic additives reduced to
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2% of the concentration formulated in CM medium as described above [12-15]. Five × 103 cells
were seeded in 60-mm culture dishes and maintained in LM medium. Growing cell colonies that
reached 0.5 mm diameter in 10 d were stained with Coomassie brilliant blue and identified as
cell clones acquiring the cancer-associated property of reduced dependence on growth factors.

Anchorage-independent cell growth assay
The base layer consisted of 2% low-melting agarose (Sigma-Aldrich) in CM medium.
Then, 0.4% low-melting agarose in a mixture (1:1) of CM medium with 3-d conditioned medium
prepared from MCF10A cultures was mixed with 1 × 104 cells and plated on top of the base layer
in 60-mm diameter culture dishes. Growing colonies that reached 0.1 mm diameter by 20 d were
identified as cell clones acquiring the cancer-associated property of anchorage-independent
growth.

Cell mobility-healing assay
Cells were seeded in 6-well plates and grown to confluence in CM medium. Cells were
rinsed with phosphate-buffered saline (PBS) and maintained in DMEM/Ham‟s F12 medium
supplemented with 2% horse serum for 15 h [41]. The monolayer was then scratched with a 23gauge needle (BD Biosciences, Franklin Lakes, NJ) to generate wounds and rinsed with CM
medium to remove floating cells. Cultures were maintained in CM medium, and the wounded
areas were examined 6 h and 20 h after scratches to detect healing. Wound healing area was
calculated using Total Lab TL100 software (Total Lab, Newcastle, NE).
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In vitro cell invasion and migration assay
The in vitro cell invasion assay was performed using 24-well Transwell insert-chambers
with a polycarbonate filter with a pore size of 8.0 μm (Corning Costar, Lowell, MA). The upper
side of the filter was coated with a Matrigel membrane (BD Biosciences). Two × 104 cells in
serum-free medium were seeded on top of the Matrigel-coated filter in each insert-chamber.
Then, insert-chambers were placed into wells on top of culture medium containing 10% horse
serum as a chemoattractant. After 24 h, the invasive ability of cells was determined by the
number of cells translocated to the lower side of filters.
The in vitro migration assay was performed using 24-well Transwell insert-chambers
with a polycarbonate filter without Matrigel. The migration ability of cells was determined by
the number of cells translocated to the lower side from the upper side of filters [42].

Mammosphere formation
Cells were seeded on 100-mm culture dishes on top of a 1% agarose-coated, nonadherent culture plate, incubated in serum-free, complete MCF10A medium supplemented with
0.4% bovine serum albumin, and maintained in 5% CO2 at 37° C for 7 to 10 d to develop
mammospheres [43].

Aldehyde dehydrogenase (ALDH) assay
An ALDEFLUOR Kit (StemCell Technologies, Vancouver, BC) was used to detect
ALDH-expressing cells. One × 105 cells/ml were resuspended in assay buffer, mixed with
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activated Aldefluor substrate BAAA (BODIPY-aminoacetaldehyde), and incubated in the
presence and absence of the ALDH inhibitor diethylaminobenzaldehyde (DEAB) at 37° C for 40
minutes. Then, cells were resuspended in assay buffer for flow cytometric analysis by using a 15
milliwatt air-cooled argon laser to produce 488 nm light [44]. Fluorescence emission was
collected with a 529-nm band pass filter. The mean fluorescence intensity of cells was quantified
using Multicycle software (Phoenix Flow System, San Diego, CA). Cells incubated with BAAA
in the presence of DEAB were used to establish the baseline of fluorescence for determining the
ALDH-expressing cell population (%) in which ALDH activity was not inhibited by DEAB.

Flow cytometric detection of CD44 and CD24 cells
Cells were trypsinzed and washed with glycine wash buffer (130 mM NaCl, 7 mM
Na2HPO4, 3.5 mM, NaH2PO4, and 100 mM glycine). Cells were then suspended in blocking
buffer (130 mM NaCl, 7 mM Na2HPO4, 3.5 mM, NaH2PO4, 8 mM NaN3, 0.1% BSA, 0.2%
TritonX-100, and 0.05% Tween 20) and incubated with phycoerythrin (PE)-conjugated CD44specific antibody and fluorescein isothiocyanate (FITC)-conjugated CD24-specific antibody (BD
Biosciences) at 4° C for 15 h. Cells were rinsed and suspended in PBS, and 1 × 105 cells/ml was
for analyzed by flow cytometry to determine the CD44+/- and CD24+/- cell populations.

Immunofluorescence detection of CD44 and CD24 cells
Mammospheres were collected, washed with glycine wash buffer, and suspended in
blocking buffer. They were then incubated with PE-conjugated CD44-specific antibody and
FITC-conjugated CD24-specific antibody at 4° C for 15 h. The mammospheres were rinsed with
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PBS and 0.1%Tween 20, detected by confocal epifluorescence microscope (Leica TCS SP2,
Leica Microsystems Heidelberg, Germany), and analyzed with Leica Lite software (Leica
Microsystems).

Western immunoblotting
Cells were lysed in buffer (10 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, 5 mM
EDTA, 10 mM sodium pyrophosphate, 10% glycerol, 0.1% Na3VO4, and 50 mM NaF, pH 7.4).
Cell lysates were isolated from the supernatants after centrifugation of crude lysates at 20,000 ×
g for 20 minutes. Protein concentration in cell lysates was measured using the BCA assay
(Pierce, Rockford, IL). Equal amounts of cellular proteins were resolved by electrophoresis in
either 10% or 14% SDS-polyacrylamide gels and transferred to nitrocellulose filters for Western
immunoblotting as previously described [12-15]. Antibodies specific to E-Cadherin, Ep-CAM,
MMP-9, Vimentin, and β-Actin were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA).

Antigen-antibody

complexes

on

filters

were

detected

by

the

Supersignal

chemiluminescence kit (Pierce).

Statistical analysis
A one-way analysis of variance (ANOVA) test was used to establish significant
difference between various treatment groups; a P value of < 0.05 was considered significant.
Then, a pairwise analysis of dependent variables was performed with the Duncan multiple range
test to verify the significance of differences between groups.
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Statistical significance of was analyzed by the Student t test; α levels were adjusted by
the Simes method [45]. A P value of < 0.05 was considered significant.
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Results
NNK- and B[a]P-induced cellular carcinogenesis
A lack of growth factors causes normal cells to become growth-arrested in the cell cycle
and to commit apoptosis; however, reduced dependence on growth factors contributes to
aberrantly-increased cell survivability and ultimately to cellular carcinogenesis [46-48]. Cell
adhesion, or anchorage, to extracellular matrixes is important for normal cell survival in a multicell environment; therefore, anchorage-independent growth also promotes aberrantly-increased
cell survivability and contributes to cellular carcinogenesis [49,50]. We have routinely used these
two cancer-associated properties of reduced dependence on growth factors and anchorageindependent growth as biological targeted endpoints for measuring the progression of chronic
cellular carcinogenesis [12-15]. As demonstrated in previous reports [14-15], cumulative
exposures of MCF10A cells to NNK and B[a]P, at physiologically-achievable concentrations of
100 pmol/L, for 5, 10, and 20 cycles (resulting in NB5, NB10, and NB20 cell lines,
respectively), induce cells to acquire increased degrees of reduced dependence on growth factors
and anchorage-independent growth, as determined by increased numbers of cell clones survived
in LM medium and soft agar, respectively. As performed in this report, additional studies
revealed that cumulative exposures to NNK and B[a]P resulted in not only increasing the number
of cell clones (Figure 4.1A-1 and 4.1B-1) but also in increasing the sizes of cell colonies,
measured as diameter, (Figure 4.1A-2 and 4.1B-2). The tumorigenic, malignant MCF10A-Ras
cell line, in which oncogenic H-Ras is ectopically expressed in MCF10A cells [51,52],
developed a significantly higher number of clones and had larger cell colonies than the
premalignant NB5, NB10, and NB20 cells (Figure 4.1A-2 and 4.1B-2). These results indicate
that cumulative exposures of breast cells to NNK and B[a]P resulted in increasing acquisition of
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cancer-associated properties of reduced dependence on growth factors and anchorageindependent growth.

NNK- and B[a]P-induced stem-like cell properties
It has been shown that stem-like cells are able to self-renew in serum-free medium and
develop mammospheres in non-adherent cultures [43]. Considering the stem-like cell property of
serum-independent, non-adherent growth, stem-like cells appear to acquire both abilities of
reduced dependence on growth factors and anchorage-independent growth that are acquired by
cells undergoing carcinogenesis. In addition, cancer stem-like cells have been postulated to play
roles in generating and maintaining premalignant and malignant lesions [37-39]. Thus, whether
cellular carcinogenesis generates stem-like cells is an important question to be clarified. Using
agarose-coated culture plates, we successfully grew mammospheres from non-cancerous
MCF10A cells, NNK- and B[a]P-exposed pre-malignant NB cells, and malignant MCF10A-Ras
cells. As shown in Figure 4.2A-1 and 4.2A-2, accumulated exposures of MCF10A cells to NNK
and B[a]P resulted in increased number and size of mammospheres in an exposure-dependent
manner, as detected in parental and pre-malignant NB5, NB10, and NB20 cultures; higher
numbers and larger sizes of mammospheres developed in MCF10A-Ras cultures than in NB20
and NB10 cultures. Breast stem-like cells have also been shown to exhibit high levels of ALDH
activity [44] and express a high level of cell surface marker CD44 with a low level of CD24 [53].
We detected significantly-increased ALDH-positive (Figure 4.2B) and CD44+/CD24- (4.2C and
4.2D) cell populations in mammospheres developed in NB10, NB20, and MCF10A-Ras cultures;
also, higher populations of ALDH-positive and CD44+/CD24- cells developed in MCF10A-Ras
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cultures than in NB20 and NB10 cultures. Apparently, cumulative exposures to NNK and B[a]P
resulted in acquisition of stem-like cell properties that may be seriously considered as a new
cancer-associated property to be used to measure progress of cellular carcinogenesis.

NNK- and B[a]P-induced EMT-associated properties and markers
Studies have shown that the EMT program is involved in development of stem-like cells
[40]. Induction of the EMT program in epithelial cells results in the cells exhibiting the
fibroblastoid morphology of mesenchymal cells with increased invasive ability [54,55]. It has
been shown that ectopic expression of oncogenic H-Ras in MCF10A cells induces mesenchymal
morphology and EMT-associated markers [56]. In investigating whether chronic NNK and B[a]P
exposure resulted in induction of the EMT program, we observed morphologic changes of
MCF10A cells from compactly-attached cobblestone-like epithelial morphology to dispersed,
spindle-like mesenchymal morphology in NB10 and NB20 cultures, as compared with MCF10ARas cells exhibiting typical mesenchymal cell morphology (Figure 4.3A). Studying EMTassociated markers, we detected decreased levels of E-Cadherin and EpCAM as well as
increased levels of Vimentin and MMP-9 in NB10, NB20, and MCF10A-Ras cells (Figure
4.3B); changes of these EMT-associated markers were in concert with the increased degrees of
cellular carcinogenesis. During the EMT reduction of E-Cadherin and EpCAM is involved in
loses of cell-cell adhesion [57,58], while an increase of MMP-9 is involved in the breakdown of
extracellular matrix [59], and increased Vimentin is involved in filament expression and
increased mobility [60]. Thus, addressing whether cellular carcinogenesis resulted in acquisition
of EMT-associated properties [55], we detected increased levels of the EMT-associated
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properties of cell migration and invasion acquired by NNK- and B[a]P-exposed, NB10 and
NB20 cells; NB20 acquired higher levels of these properties than NB10 and comparable levels to
MCF10A-Ras cells (Figure 4.3C and 4.3D). In addition, using a scratch/wound assay [41], we
detected that NB20 cells acquired higher degrees of cell mobility than NB10 and NB5 cells, and
NB20 cells acquired a comparable degree of cell mobility to MCF10A-Ras cells (Figure 4.3E-1
and 4.3E-2). Accordingly, these results indicate that cumulative exposures to NNK and B[a]P
resulted in acquisition of EMT-associated properties in an exposure cycle-dependent manner;
thus, EMT-associated properties and markers may be considered as new cancer-associated
properties to be used as targeted endpoints to measure progress of cellular carcinogenesis.

GTC and GSPE suppression of NNK- and B[a]P-induced cellular carcinogenesis
Using the cancer-associated properties of reduced dependence on growth factors and
anchorage-independent growth as biological targeted endpoints, we investigated the activity of
GTC and GSPE in suppression of NNK- and B[a]P-induced cellular carcinogenesis. Consistent
with our reported results [14-15], GTC and GSPE at their maximal, non-cytotoxic concentration
of 40 µg/mL were effective in suppressing the number of cell clones acquiring reduced
dependence on growth factors and anchorage-independent growth (Figure 4.4A-1 and 4.4B-1).
Cumulative exposures of MCF10A cells to NNK and B[a]P in the presence of GTC and GSPE
for 20 cycles resulted in NB/T-20 and NB/G-20 cell lines, respectively. Here, we performed
additional studies to reveal that co-exposure to GTC and GSPE resulted in not only decreasing
the number of cell clones (Figure 4.4A-1 and 4.4B-1) but also in decreasing cell abilities of
reduced dependence on growth factors (4.4A-2) and anchorage-independent growth (4.4B-2), as
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determined by decreased sizes of cell colonies in NB/T-20 and NB/G-20 cultures versus NB20
cultures. These results indicate that non-cytotoxic GTC and GSPE were able to qualitatively and
quantitatively suppress NNK- and B[a]P-induced cellular carcinogenesis.
GTC and GSPE suppression of NNK- and B[a]P-induced stem-like cell properties
Using the stem-like cell properties of mammosphere formation and increased ALDHpositive and CD44+/CD24- cell populations as targeted endpoints, we furthered our
understanding of the activity of GTC and GSPE in suppression of NNK- and B[a]P-induced
cellular carcinogenesis. As shown in Figure 4.5A, co-exposure to GTC and GSPE significantly
reduced not only the number but also the size of mammospheres induced by NNK and B[a]P.
Co-exposure to GTC and GSPE also significantly reduced ALDH-positive (Figure 4.5B) and
CD44+/CD24- (4.5C) cell populations in mammospheres, as determined in NB/T-20 and
NB/G20 cultures versus NB20 cultures. These results indicate that non-cytotoxic GTC and
GSPE were able to suppress NNK- and B[a]P-induced stem cell-like properties.

GTC and GSPE suppression of NNK- and B[a]P-induced EMT-associated properties and
markers
Using EMT-associated cell morphology, markers and properties as targeted endpoints,
we investigated the activity of GTC and GSPE in suppression of NNK- and B[a]P-induced
cellular carcinogenesis. As shown in Figure 4.6A, mesenchymal-like cell morphology in NB20
cultures was not detected in NB/T-20 and NB/G20 cultures. Expression of E-Cadherin and
EpCAM was reduced in NB20 cells but not in NB/T-20 and NB/G20 cells, and increased MMP9 and Vimentin in NB20 cells were reversed in NB/T-20 and NB/G20 cells (Figure 4.6B). In
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addition, the EMT-associated properties of increased cell migration (Figure 4.6C), invasion
(4.6D), and mobility (4.6E-1 and 4.6E-2) acquired by NB20 cells were reversed in in NB/T-20
and NB/G20 cells. These results indicate that non-cytotoxic GTC and GSPE were able to protect
epithelial cells from developing NNK- and B[a]P-induced EMT-associated morphological
features, markers, and properties.

Discussion
Cumulative exposures of non-cancerous human breast epithelial MCF10A to the
carcinogens NNK and B[a]P, at physiologically-achievable concentrations, result in progression
of cellular carcinogenesis to premalignant stages. This progression is measured by cellular
acquisition of progressively-increased degrees of cancer-associated properties in an exposuredependent manner, without acquiring tumorigenicity [11-15]. Although cellular acquisition of
tumorigenicity is regarded as the gold standard for validating cell malignancy, many human
cancer cells are not tumorigenic, such as urinary bladder cancer J82 cells [61]. Thus, using
various other cancer-associated properties as measurable targeted endpoints should be seriously
considered in studying cellular carcinogenesis progression and intervention of cellular
carcinogenesis.
In this study, we presented results to reveal the values of acquisition of stem-like cell
properties as well as EMT-associated markers and properties in measuring the induction of
chronic cellular carcinogenesis. Epithelial cells chronically exposed to NNK and B[a]P
increasingly acquired stem-like cell properties of mammosphere formation and increased
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populations of ADLH-positive and CD44+/CD24- stem-like cells in mammospheres. The ability
of carcinogen-exposed epithelial cells to develop mammospheres in serum-free non-adherent
cultures may be related to their combined abilities of reduced dependence on growth factors and
anchorage-independent growth. The ability of carcinogenic epithelial cells to produce increased
stem-like cell populations in mammospheres may be mediated by the EMT program, as indicated
by many studies [43,56,62]. Our results revealed that the EMT-associated properties of
mesenchymal morphology, cell migration, invasion, and mobility, as well as the EMT-associated
markers of losing E-Cadherin and EpCAM and gaining MMP-9 and Vimentin were also
increasingly acquired by epithelial cells chronically exposed to NNK and B[a]P. Accordingly,
this exposure resulted in induction of the EMT program in epithelial cells, which in turn,
supported development of mammospheres and an increase in stem-like cell population. Although
cumulative exposures to NNK and B[a]P for 20 cycles failed to induce cellular acquisition of
stem-like cell and EMT-associated properties to comparable levels acquired by tumorigenic,
malignant MCF10A-Ras cells, the increased degrees of these properties acquired by the nontumorigenic, pre-malignant NNK- and B[a]P-exposed cells clearly revealed a carcinogenesis
progression in an exposure cycle-dependent manner. Cancer stem-like cells have been postulated
to play important roles in pre-malignant and malignant stages of cancer development [37-39],
and cancer stem-like cells also play an important role in recurrent cancers after chemotherapy
[63]. Thus, it is important to consider cellular acquisition of stem-like cell and EMT-associated
properties and markers as new targeted endpoints in measuring carcinogenesis progression.
For the first time, we demonstrated the activity of non-cytotoxic dietary green tea and
grape seed extracts in suppression of stem-like cell properties and EMT-associated properties
and markers induced by long-term exposure to NNK and B[a]P at a bio-achievable dose.
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Previously, we showed that GTC and GSPE, at a non-cytotoxic concentration of 40 µg/ml,
effectively blocked NNK- and B[a]P-induced acquisition of the cancer-associated properties of
reduced dependence on growth factors, anchorage-independent growth, and acinarconformational disruption [11-15]. Here, we revealed that co-exposure to GTC and GSPE was
effective in suppressing cellular acquisition of increased abilities of mammosphere formation,
stem-like cell population, cell migration, invasion, and mobility induced by long-term exposure
to NNK and B[a]P. The activity of dietary GTC and GSPE to protect epithelial cells from
acquiring stem-like cell and EMT-associated properties prevented epithelial cells from producing
stem-like and mesenchymal cells. GTC and GSPE suppression of cellular acquisition of stemlike cell- and EMT-associated properties were indicated by reduction of the increased ADLHpositive and CD44+/CD24- cell populations and reversal of changes in expression of E-Cadherin,
EpCAM, MMP-9, and Vimentin. However, whether dietary GTC and GSPE are able to protect
mammary tissues from acquiring carcinogen-induced stem-like cell and EMT-associated
properties to reduce the risk of invasive tumors, indicated by suppression of stem-like cell- and
EMT-associated markers, remains to be studied.
Our model presents a unique feature in that it is able to determine chronic breast cell
carcinogenesis progression induced by cumulative exposures to carcinogens at a physiologicallyachievable dose. Using our model, we demonstrated that chronic carcinogenesis was
accompanied with acquisition of stem-like cell and EMT-associated properties and markers.
These measurable properties and markers should be considered as new cancer-associated
properties in studies of breast cell carcinogenesis and may serve as new targeted endpoints in
detection of carcinogenesis progression. Thus, our system provides a platform equipped with
measurable targeted endpoints to identify preventive agents effective in suppression of cellular
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carcinogenesis induced by long-term exposure to carcinogens. NNK and B[a]P are recognized as
potent environmental carcinogens in the development of pulmonary cancers [16,17]. Although
NNK and B[a]P may not induce tumorigenic carcinogenesis of breast cells, they induce cellular
acquisition of various cancer-associated properties, including stem-like and EMT-associated
properties; therefore, their carcinogenic roles in breast cancer development, even in premalignant stages, should be recognized. Indeed, prevention of cellular carcinogenesis at various
stages is the key to reduce the risk of cancer development, and effective intervention of premalignant carcinogenesis is highly important in cancer prevention. It is important to consider the
use of non-cytotoxic, dietary GTC and GSPE in early prevention of pre-malignant cell
carcinogenesis in sporadic breast cancer development associated with long-term exposure to low
doses of environmental carcinogens. Furthering technology of using dietary GTC and GSPE in
prevention of pre-malignant cell carcinogenesis, especially to intervene in acquisition of stemlike cell and EMT-associated properties, may allow us to overcome a current obstacle in control
of cancer stem-like cell resistance to therapeutic agents.
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Figure 4.1. NNK- and B[a]P-induced cellular carcinogenesis. MCF10A (10A) cells were
repeatedly exposed to NNK combined with B[a]P each at 100 pmol/L for 5, 10, and 20 cycles,
resulting in NB5, NB10, and NB20 cell lines, respectively. MCF10A cells were stably
transfected to ectopically express oncogenic H-Ras, resulting in MCF10A-Ras (10A-Ras) cells.
(A-1 and A-2) To determine cellular acquisition of the cancer-associated property of reduced
dependence on growth factors, cells were seeded in LM medium for 10 d; cell colonies (≥ 0.5
mm diameter) were counted (A-1). (B-1 and B-2) To determine cellular acquisition of the
cancer-associated property of anchorage-independent growth, cells were seeded in soft-agar for
20 d; cell colonies (≥ 0.1 mm diameter) were counted (B-1). Columns, mean of triplicates; bars,
SD. All results are representative of 3 independent experiments. The Student t test was used to
analyze statistical significance, indicated by * P < 0.05, ** P < 0.01, *** P < 0.001; α levels
were adjusted by the Simes method. (A-2 and B-2) Tables show colony numbers, average colony
size, and range of colony size developed in LM medium and soft-agar, respectively. Mean
colony numbers in each group were analyzed by one-way ANOVA at P < 0.001 to indicate
significant difference in number of colonies in various groups. To further determine the
significant difference between individual groups, a pairwise analysis of variables was performed
using the Duncan multiple range test. Means with different superscript letters (a, b, c, d, and e)
indicate significant difference at P < 0.001 between groups; no significant difference was seen
between groups with the same superscript.
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Figure 4.1.
NNK- and B[a]P-induced cellular carcinogenesis.
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Figure 4.2. NNK- and B[a]P-induced stem-like cell properties. (A-1 and A-2) To determine
cellular acquisition of the ability of serum-independent non-adherent growth, 1 × 104 MCF10A
(10A), NB5, NB10, NB20, and MCF10A-Ras (10A-Ras) cells were seeded in non-adherent
cultures for 10 d; then, mammospheres (≥ 0.1 mm diameter) were counted (A-1). Columns, mean
of triplicates; bars, SD. The Student t test was used to analyze statistical significance, indicated
by ** P < 0.01, *** P < 0.001; α levels were adjusted by the Simes method. (A-2) Table shows
mammosphere numbers, average size, and range of size. Mean mammosphere numbers in each
group were analyzed by one-way ANOVA at P < 0.001 to indicate significant difference in
number of colonies in various groups. To further determine the significant difference between
individual groups, a pairwise analysis of variables was performed using the Duncan multiple
range test. Means with different superscript letters (a, b, c, and d) indicate significant difference
at P < 0.001 between groups; no significant difference was seen between groups with the same
superscript. (B) Epithelial (white columns), primary (light grey columns), and secondary (dark
grey columns) mammospheres were collected for detection of ALDH-expressing (ALDH+) cell
population (%). (C) Representative images of co-immuno-staining of 10A and NB20
mammospheres with PE-conjugated CD44-specific antibody and FITC-conjugated CD24specific antibody. Bars, 100µm. Arrow head indicates CD44+/CD24- cell. (D) Mammospheres
were co-labeled with PE-conjugated CD44-specific antibody and FITC-conjugated CD24specific antibody, and CD44+/CD24- cell population (%) was determined by flow cytometry.
Columns, mean of triplicates; bars, SD. All results are representative of at least 3 independent
experiments. The Student t test was used to analyze statistical significance, indicated by * P <
0.05, ** P < 0.01, *** P < 0.001; α levels were adjusted by the Simes method.
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Figure 4.3. NNK- and B[a]P-induced EMT-associated properties. (A) Representative
morphological features of MCF10A (10A), NB10, NB20, and MCF10A-Ras (10A-Ras) cells,
400X. (B) Cell lysates were analyzed by Western immunoblotting using specific antibodies to
detect levels of EpCAM, E-Cadherin, MMP-9, and Vimentin, with β-Actin as a control, and
these levels were quantified by densitometry. The levels of EpCAM, E-Cadherin, MMP-9, and
Vimentin were calculated by normalizing with the level of β-Actin and the level set in 10A cells
(lane 1) as 1 (X, arbitrary unit). All results are representative of at least 3 independent
experiments. (C) Cellular migratory and (D) invasive activities were determined by counting the
numbers of cells translocated through polycarbonate filter without or with coated Matrigel,
respectively, in 10 arbitrary visual fields. Columns, mean of triplicates; bars, SD. The Student t
test was used to analyze statistical significance, indicated by * P < 0.05, ** P < 0.01, *** P <
0.001; α levels were adjusted by the Simes method. (E-1 and E-2) Cellular acquisition of
increased mobility was determined by wound healing assay. Cells were seeded in CM medium
and grown to confluence (E-1, a); then, a linear area of cell layer was removed from each culture
with a 23-gauge needle to produce wounded cultures, and the wounded areas were examined
(×100 magnification) 6 (b) and 20 h (c) after wounding. Arrows indicate width of wounded
areas. Results are representative of 3 independent experiments. (E-2) To quantitatively measure
cell mobility detected in (E-1), the area not healed by the cells was subtracted from the total area
of the initial wound to calculate the wound healing area (%) at time intervals of 6 (white
columns) and 20 h (grey columns). Columns, mean of triplicates; bars, SD. All results are
representative of 3 independent experiments. The Student t test was used to analyze statistical
significance, indicated by * P < 0.05, ** P < 0.01, *** P < 0.001; α levels were adjusted by the
Simes method.
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Figure 4.3.
NNK- and B[a]P-induced EMT-associated properties.
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Figure 4.4. GTC and GSPE suppression of NNK- and B[a]P-induced cellular
carcinogenesis. MCF10A (10A) cells were repeatedly exposed to NNK combined with B[a]P
each at 100 pmol/L in the presence of GTC and GSPE at 40µg/ml for 20 cycles, resulting in
NB/T-20 and NB/G-20 cell lines, respectively. (A-1 and A-2) To determine acquisition of the
cancer-associated property of reduced dependence on growth factors, 10A, NB20, NB/T-20, and
NB/G-20 cells were seeded in LM medium for 10 d; cell colonies (≥ 0.5 mm diameter) were
counted (A-1). (B-1 and B-2) To determine cellular acquisition of the cancer-associated property
of anchorage-independent growth, cells were seeded in soft agar for 20 d; cell colonies (≥ 0.1
mm diameter) were counted (B-1). Columns, mean of triplicates; bars, SD. All results are
representative of 3 independent experiments. The Student t test was used to analyze statistical
significance, indicated by ** P < 0.01, *** P < 0.001; α levels were adjusted by the Simes
method. (A-2 and B-2) Tables show colony numbers, average colony size, and range of colony
size developed in LM medium and soft agar, respectively. Mean colony numbers in each group
were analyzed by one-way ANOVA at P < 0.001 to indicate significant difference in number of
colonies in various groups. To further determine the significant difference between individual
groups, a pairwise analysis of variables was performed using the Duncan multiple range test.
Means with different superscript letters (a, b, and c) indicate significant difference at P < 0.001
between groups; no significant difference was seen between groups with the same superscript.
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Figure 4.4.
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Figure 4.5. GTC and GSPE suppression of NNK- and B[a]P-induced stem-like cell
properties. (A-1 to A-3) To determine cellular acquisition of the ability of serum-independent
non-adherent growth, 1 × 104 MCF10A (10A), NB20, NB/T-20, and NB/G-20 cells were seeded
in non-adherent cultures for 10 d; then, mammospheres (≥ 0.1 mm diameter) were counted (A1). Columns, mean of triplicates; bars, SD. The Student t test was used to analyze statistical
significance, indicated by *** P < 0.001; α levels were adjusted by the Simes method. (A-2)
Representative fields of mammosphere cultures. (A-3) Table shows mammosphere numbers,
average size, and range of size. Mean mammosphere numbers in each group were analyzed by
one-way ANOVA at P < 0.001 to indicate significant difference in number of colonies in various
groups. To further determine the significant difference between individual groups, a pairwise
analysis of variables was performed using the Duncan multiple range test. Means with different
superscript letters (a, b, and c) indicate significant difference at P < 0.001 between groups; no
significant difference was seen between groups with the same superscript. (B) Parental epithelial
cells (white columns) and the primary (grey columns) and secondary (dark columns)
mammospheres were trypsinized, and ALDH-expressing (ALDH+) cell population (%) was
determined by flow cytometry. (C) Mammospheres were trypsinized, cells were incubated with
PE-conjugated CD44-specific antibody and FITC-conjugated CD24-specific antibody, and
CD44+/CD24- cell population (%) was determined by flow cytometry. Columns, mean of
triplicates; bars, SD. All results are representative of at least 3 independent experiments. The
Student t test was used to analyze statistical significance, indicated by * P < 0.05, ** P < 0.01,
*** P < 0.001; α levels were adjusted by the Simes method.
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Figure 4.5.
GTC and GSPE suppression of NNK- and B[a]P-induced stem-like cell properties.
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Figure 4.6. GTC and GSPE suppression of NNK- and B[a]P-induced EMT-associated
properties. (A) Representative morphological features of MCF10A (10A), NB20, NB/T-20, and
NB/G-20 cells, 400X. (B) Cell lysates were analyzed by Western immunoblotting using specific
antibodies to detect levels of EpCAM, E-Cadherin, MMP-9, and Vimentin, with β-Actin as a
control, and these levels were quantified by densitometry. The levels of EpCAM, E-Cadherin,
MMP-9, and Vimentin were calculated by normalizing with the level of β-Actin and the level set
in 10A cells (lane 1) as 1 (X, arbitrary unit). (C) Cellular migratory and (D) invasive activities
were determined by counting the numbers of cells translocated through polycarbonate filter
without or with coated Matrigel, respectively, in 10 arbitrary visual fields. Columns, mean of
triplicates; bars, SD. The Student t test was used to analyze statistical significance, indicated by
** P < 0.01, *** P < 0.001; α levels were adjusted by the Simes method. (E-1 and E-2) Cellular
acquisition of increased mobility was determined by wound healing assay. Cells were seeded in
CM medium and grown to confluence (E-1, a); then, a linear area of cell layer was removed from
each culture with a 23-gauge needle to produce wounded cultures, and the wounded areas were
examined (×100 magnification) 6 (b) and 20 h (c) after wounding. Arrows indicate width of
wounded areas. Results are representative of 3 independent experiments. (E-2) To quantitatively
measure cell mobility detected in (E-1), the area not healed by the cells was subtracted from the
total area of the initial wound to calculate the wound healing area (%) at time intervals of 6
(white columns) and 20 h (grey columns). Columns, mean of triplicates; bars, SD. The Student t
test was used to analyze statistical significance, indicated by * P < 0.05, ** P < 0.01, *** P <
0.001; α levels were adjusted by the Simes method.

217

Figure 4.6.
GTC and GSPE suppression of NNK- and B[a]P-induced EMT-associated properties
218

PART-V
General Discussion

219

General Discussion
The study presented in the dissertation was designed to (1) investigate the intervention of
chronic breast cell carcinogenesis induced by environmental carcinogens in MCF10A cells by
dietary compounds like green tea catechins and grape seed extract and, (2) study the importance
of epithelial to mesenchymal transition and stem-like cells in chronically induced carcinogenesis.

Intervention of chronic breast cell carcinogenesis induced by environmental carcinogens in
MCF10A cells
Prevention of human breast cell carcinogenesis associated with chronic exposure to low
doses of environmental carcinogens is an under-investigated area. Our model system presents
unique features of mimicking chronically-induced carcinogenesis of human breast cells to
increasingly acquire cancer-associated properties induced by chronic, cumulative exposures to
carcinogens at low concentrations in the pico-molar range, as in environmental exposure. In
contrast, many cell systems have been developed to study the activity of carcinogens at high
concentrations in the micro-molar range, as in occupational exposure, in acute induction of
cellular carcinogenesis [1-8]. Using our cellular model as a target system, we are able to verify
the preventive activity of complete green tea extract and individual catechins (at non-cytotoxic
levels) in suppression of chronic cellular carcinogenesis. In addition we have identified the
mechanisms through which the catechins can counteract the biological, biochemical, and
molecular effects of NNK and B[a]P. Based on our results, use of non-cytotoxic catechin
components should be seriously considered in prevention of cellular carcinogenesis induced by
chronic exposure to environmental carcinogens.
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Our studies revealed that cumulative exposures to NNK and/or B[a]P at a bio-achievable
concentration of 100 pmol/L resulted in progression of human breast cells to increasingly acquire
cancer-associated properties in an exposure-dependent manner, without acquiring tumorigenicity
[9-12]. Although cellular acquisition of tumorigenicity is regarded as the gold standard for
validating cell malignancy, many human cancer cells, such as MDA-MB-453 [13] and urinary
bladder cancer J82 cells are not tumorigenic [14]. We have shown that cumulative exposures of
MCF10A cells to NNK and B[a]P at 100 pmol/L for 10 and 20 cycles induce the cancerassociated property of reduced dependence on growth factors, anchorage independent growth ,
increased cell motility and acinar-conformational disruption with irregular spheroids developed
on Matrigel [9-12]. Green tea extract and individual catechins were able to suppress these
carcinogen induced cancerous properties. Acinar structures with a hollow lumen and
apicobasally polarized cells are important characteristics found in glandular epithelia in vivo.
The disruption of an intact glandular structure is a hallmark of epithelial cancer, even at its
earliest premalignant stages, such as ductal carcinoma in-situ (DCIS) [15-17]. Clinically, breast
cells involved in DCIS are not malignant and have not acquired the ability to invade adjacent
tissues through the ductal or lobular wall, but often premalignant cells can either develop into
malignant cells or increase the risk of becoming malignant [3,18,19]. Thus, in addition to
tumorigenicity, using various cancer-associated properties as measurable targeted endpoints
should be seriously considered in studying cellular carcinogenesis and intervention of cellular
carcinogenesis.
Short-term exposure to NNK and B[a]P at 100 pmol/L induced transient ROS elevation
leading to ERK pathway activation, cell proliferation, and chromosomal DNA damage.
However, these short-term targeted endpoints were transient; they were not permanent in cells
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acquiring cancer-associated properties induced by cumulative exposures to NNK and B[a]P.
Aiming at these transiently-induced, short-term targeted endpoints, we observed that green tea
catechins EC, ECG, EGC, and EGCG, at a non-cytotoxic concentration of 10 µg/mL, were
capable of blocking NNK- and B[a]P-induced ROS elevation, ERK pathway activation, cell
proliferation, and DNA damage to various extents in non-cancerous MCF10A and in
adenocarcinoma MCF7 cells. Interestingly, ECG was more effective than EC, EGC, and EGCG
in suppression of cellular carcinogenesis, measured by degrees of acquired cancer-associated
properties in long-term targeted carcinogenic endpoints, permanently induced by cumulative
exposures to NNK and B[a]P. However, whether the activity of individual catechins may vary in
suppression of cellular carcinogenesis induced by other carcinogens remains to be addressed.
ECG was also less cytotoxic to MCF10A cells than EGCG and EGC. Studies of the
hepatotoxicity of GTCs in rats showed that EGCG is the most toxic of all four catechins; for
example, the LD50 for EGCG (200 µM) was 10 times lower than that for ECG (2000 µM),
indicating that ECG is much less toxic than EGCG [20]. Thus, the cytotoxicity-independent
ability of these catechins to block NNK- and B[a]P-induced, ROS elevation, ERK pathway
activation, cell proliferation, and DNA damage in each short-term exposure accounted for their
effectiveness in suppression of breast cell carcinogenesis induced by long-term, accumulated
exposure to NNK and B[a]P.
NNK- and B[a]P-induced ROS elevation played a key role in activation of the ERK
pathway, leading to cell proliferation and DNA damage. Studies have shown that ROS is able to
induce the ERK pathway via activation of membrane-associated growth factor receptors or via
Raf-independent Mek1/2 activation [21,22]. In our studies, exposure of MCF10A cells to NNK
and B[a]P did not induce any detectable upregulation of Ras or Raf, both of which are upstream
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from Mek1/2 and Erk1/2. Thus, NNK- and B[a]P-elevated ROS induced the ERK pathway in a
Raf-independent manner. However, how ROS was induced by NNK and B[a]P in MCF10A and
MCF7 cells, and how ROS was able to induce Raf-independent activation of Mek1/2 and Erk1/2
remain to be determined.
Our model system addresses breast cell carcinogenesis induced by chronic exposure to
carcinogens at bio-achievable levels and identifies preventive agents, at non-cytotoxic levels,
capable of suppressing chronically-induced breast cell carcinogenesis. We demonstrated, for the
first time, use of a new powerful two-step strategy. The first step uses short-term biological,
biochemical, and molecular targeted carcinogenic endpoints transiently induced by short-term
exposure to carcinogens for detecting preventive agents capable of blocking cellular
carcinogenesis. The second step subsequently uses long-term biological, biochemical, and
molecular targeted carcinogenic endpoints induced by chronic exposure to carcinogens to verify
preventive agents effective in suppression of cellular carcinogenesis. Our model system presents
unique features of mimicking chronically-induced carcinogenesis of human breast cells to
increasingly acquire cancer-associated properties induced by chronic, cumulative exposures to
carcinogens at low concentrations in the pico-molar range, as in environmental exposure. Using
our model system will conceivably accelerate the identification of additional preventive agents
that are effective in reducing the health risk of sporadic breast cancer associated with chronic
exposure to carcinogens present in environmental pollution.
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The importance of epithelial to mesenchymal transition and stem-like cells in chronically
induced carcinogenesis and its dietary prevention
In this study, we presented results that reveal the value of acquisition of stem-like cell
properties as well as EMT-associated markers and properties, in measuring the induction of
chronic cellular carcinogenesis. Epithelial cells chronically exposed to NNK and B[a]P
increasingly acquired stem-like cell properties of mammosphere formation and increased
populations of ADLH-positive and CD44+/CD24- stem-like cells in mammospheres. The ability
of carcinogen-exposed epithelial cells to develop mammospheres in serum-free non-adherent
cultures may be related to their combined abilities of reduced dependence on growth factors and
anchorage-independent growth. The ability of carcinogenic epithelial cells to produce increased
stem-like cell populations in mammospheres may be mediated by the EMT program, as indicated
by many previous studies [23-25]. Our results revealed that the EMT-associated properties of
mesenchymal morphology, cell migration, invasion, and mobility, as well as the EMT-associated
markers of losing E-Cadherin and EpCAM and gaining MMP-9 and Vimentin were also
increasingly acquired by epithelial cells chronically exposed to NNK and B[a]P. Accordingly,
this exposure resulted in induction of the EMT program in epithelial cells, which in turn,
supported development of mammospheres and an increase in stem-like cell population. Although
cumulative exposures to NNK and B[a]P for 20 cycles failed to induce cellular acquisition of
stem-like cell and EMT-associated properties to comparable levels acquired by tumorigenic,
malignant MCF10A-Ras cells, the increased degrees of these properties acquired by the nontumorigenic, pre-malignant NNK- and B[a]P-exposed cells clearly revealed a carcinogenesis
progression in an exposure cycle-dependent manner. Cancer stem-like cells have been postulated
to play important roles in pre-malignant and malignant stages of cancer development [26-28],
224

and cancer stem-like cells also play an important role in recurrent cancers after chemotherapy
[29]. Thus, it is important to consider cellular acquisition of stem-like cell and EMT-associated
properties and markers as new targeted endpoints in measuring carcinogenesis progression.
For the first time, we demonstrated the activity of non-cytotoxic dietary green tea and
grape seed extracts in suppression of stem-like cell properties and EMT-associated properties
and markers induced by long-term exposure to NNK and B[a]P at a bio-achievable dose.
Previously, we showed that GTC and GSPE, at a non-cytotoxic concentration of 40 µg/ml,
effectively blocked NNK- and B[a]P-induced acquisition of the cancer-associated properties of
reduced dependence on growth factors, anchorage-independent growth, and acinarconformational disruption [9-12]. Here, we revealed that co-exposure to GTC and GSPE was
effective in suppressing cellular acquisition of increased abilities of mammosphere formation,
stem-like cell population, cell migration, invasion, and mobility induced by long-term exposure
to NNK and B[a]P. The activity of dietary GTC and GSPE to protect epithelial cells from
acquiring stem-like cell and EMT-associated properties prevented epithelial cells from producing
stem-like and mesenchymal cells. GTC and GSPE suppression of cellular acquisition of stemlike cell- and EMT-associated properties were indicated by reduction of the increased ADLHpositive and CD44+/CD24- cell populations and reversal of changes in expression of E-Cadherin,
EpCAM, MMP-9, and Vimentin. However, whether dietary GTC and GSPE are able to protect
mammary tissues from acquiring carcinogen-induced stem-like cell and EMT-associated
properties to reduce the risk of invasive tumors, indicated by suppression of stem-like cell- and
EMT-associated markers, remains to be studied.
Our model presents a unique feature in that it is able to determine chronic breast cell
carcinogenesis progression induced by cumulative exposures to carcinogens at a physiologically225

achievable dose. Using our model, we demonstrated that chronic carcinogenesis was
accompanied with acquisition of stem-like cell and EMT-associated properties and markers.
These measurable properties and markers should be considered as new cancer-associated
properties in studies of breast cell carcinogenesis and may serve as new targeted endpoints in
detection of carcinogenesis progression. Thus, our system provides a platform equipped with
measurable targeted endpoints to identify preventive agents effective in suppression of cellular
carcinogenesis induced by long-term exposure to carcinogens. NNK and B[a]P are recognized as
potent environmental carcinogens in the development of pulmonary cancers [30,31]. Although
NNK and B[a]P may not induce tumorigenic carcinogenesis of breast cells, they induce cellular
acquisition of various cancer-associated properties, including stem-like cell and EMT-associated
properties; therefore, their carcinogenic roles in breast cancer development, even in premalignant stages, should be recognized. Indeed, prevention of cellular carcinogenesis at various
stages is the key to reduce the risk of cancer development, and effective intervention of premalignant carcinogenesis is highly important in cancer prevention. It is important to consider the
use of non-cytotoxic, dietary GTC and GSPE in early prevention of pre-malignant cell
carcinogenesis in sporadic breast cancer development associated with long-term exposure to low
doses of environmental carcinogens. Furthering technology of using dietary GTC and GSPE in
prevention of pre-malignant cell carcinogenesis, especially to intervene in acquisition of stemlike cell and EMT-associated properties, may allow us to overcome a current obstacle in control
of cancer stem-like cell resistance to therapeutic agents.
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Summary
This study has shown that repeated exposure of non-cancerous, human breast epithelial
MCF10A cells with low dose environmental carcinogens NNK and B[a]P induces various
cancer-associated properties like reduced dependence on growth factors, anchorage independent
growth, increased cell motility and acinar-conformational disruption. We detected the ability of
dietary compounds like green tea extract, individual catechins from green tea and grape seed, at
non-cytotoxic concentrations to suppress chronically -induced carcinogenesis of breast epithelial
cells. This is summarized in the scheme shown in Figure 5.1.
To identify the mechanism involved in chronic carcinogenesis we identified short-term
biological, biochemical, and molecular targeted carcinogenic endpoints transiently induced by
short-term exposure to carcinogens for detecting preventive agents capable of blocking cellular
carcinogenesis. Short-term exposure to NNK and B[a]P at 100 pmol/L induced transient ROS
elevation leading to ERK pathway activation, cell proliferation, and chromosomal DNA damage
(Figure 5.2). We also observed that green tea catechins EC, ECG, EGC, and EGCG, at a noncytotoxic concentration of 10 µg/mL, were capable of blocking NNK- and B[a]P-induced ROS
elevation, ERK pathway activation, cell proliferation, and DNA damage to various extents.
We further investigated stem-like cell- and EMT-associated properties and markers
progressively induced by chronic exposure of breast epithelial cells to NNK and B[a]P. We also
used stem-like cell- and EMT-associated properties and markers as targeted endpoints to verify
the activity of non-cytotoxic GTC and GSPE in suppression of NNK- and B[a]P-induced cellular
carcinogenesis.
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Prospects
Our study shows that NNK- and B[a]P-elevated ROS induced the ERK pathway in a Rafindependent manner. However, how ROS was induced by NNK and B[a]P in MCF10A and
MCF7 cells, and how ROS was able to induce Raf-independent activation of Mek1/2 and Erk1/2
remain to be determined.
We have shown the exposure of MCF10A cells to NNK and B[a]P at 100 pmol/L for 20
cycles can induce various cancer-associated properties, but no tumorigenicity in mice, therefore
it is important to identify that if further treatment with carcinogens will render the cell to be
tumorigenic or whether treating the with additional carcinogens might lead to tumorigenicity.
GTC and GSPE suppression of cellular acquisition of stem-like cell- and EMT-associated
properties were indicated by reduction of the increased ADLH-positive and CD44+/CD24- cell
populations and reversal of changes in expression of E-Cadherin, EpCAM, MMP-9, and
Vimentin. However, whether or not dietary GTC and GSPE are able to protect mammary tissues
from acquiring carcinogen-induced stem-like cell and EMT-associated properties to reduce the
risk of invasive tumors, indicated by suppression of stem-like cell- and EMT-associated markers,
remains to be studied.
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APPENDIX
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Figure 5.1
Schematic indication rogressive induction of cancer-associated properties with exposure to
carcinogens and its suppression by dietary compounds.
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Figure 5.2
(A) Hypothetical scheme of carcinogen-induced ROS, cell proliferation and DNA
damage
(B) Hypothetical scheme of suppression of carcinogen-induced ROS, cell proliferation
and DNA damage by green tea (indicated by green cross).
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